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Preface
Family planning and taking care of reproductive health allows families to attain 
their desired number of children and maintain a good family health status. This is 
achieved by improving the lives of women, children, and families through public 
health monitoring, scientific assistance, and research.
Many factors need to be considered by couples at certain points in their reproductive 
period when considering family planning. Choosing a contraceptive method would 
include the aspects of safety, effectiveness, accessibility, affordability, and accept-
ability. Family planning reduces the need for abortion and maternal morbidity and 
mortality.
A woman’s reproductive health is delicate and complex. Taking care and making 
healthy choices can help protect mothers and children. Reproductive health should 
be high on the priorities list.
The content of this book covers some aspects of family planning and deals with a 
number of issues that pertain to reproductive health.
The editors are thankful to all the authors for their contributions, and would like to 
thank Ms. Sara Debeuc, Author Service Manager, and all commissioning editors for 
their support and advice.
Zouhair O. Amarin
Professor,
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Venous Thromboembolism in the 
Context of Reproduction: The 
Royal College of Obstetricians and 
Gynecologists Recommendations
Zouhair O. Amarin and Mahmoud A. Alfaqih
Abstract
Venous thromboembolism complicates 1–2 of every 1000 deliveries. It may 
manifest as deep vein thrombosis or pulmonary embolism. Pregnancy-associated 
venous thromboembolism is an important major cause of maternal morbidity and 
mortality. Prophylaxis and therapy in pregnancy are complicated by the need to 
take both fetal and maternal well-being into consideration. Risk factors for venous 
thromboembolism during pregnancy or the puerperium are multiple. They include, 
but are not limited to, thrombophilia, multiparity, orthopedic injuries, medical 
comorbidities, prior venous thromboembolism, smoking, gross varicose veins, 
age, if older than 35, obesity, multiple pregnancy, preeclampsia, cesarean section, 
prolonged labor, instrumental vaginal delivery, stillbirth, preterm birth, postpar-
tum hemorrhage, hyperemesis gravidarum, ovarian hyperstimulation syndrome, 
immobility, long periods of hospitalization, and long haul travel. This chapter is a 
clinical guide that covers prophylaxis and therapy of pregnancy-associated venous 
thromboembolism, based on evidence-based research and consensus opinion.
Keywords: obstetrics, pregnancy, prophylaxis, deep vein thrombosis,  
pulmonary embolism, anticoagulants
1. Introduction
Worldwide, childbearing carries a major risk to the life of women [1]. The 
Millennium Development Goals (MDGs) were the eight international development 
goals, and the 192 United Nations states and 23 international organizations had agreed 
to achieve those goals. Reducing maternal mortality by three quarters over 15 years 
was a specific part of Goal 5 (Improving Maternal Health) of the eight MDGs [2].
The WHO defines maternal mortality as “the death of a woman while pregnant 
or within 42 days of termination of pregnancy, irrespective of the duration and site 
of the pregnancy, from any cause related to or aggravated by the pregnancy or its 
management but not from accidental or incidental causes” [3].
The maternal mortality ratio (MMR) is a key performance indicator for efforts 
to improve the safety of mothers before, during, and after childbirth per country. 
It is the annual number of deaths per 100,000 live births from causes related to or 
aggravated by pregnancy or its management (not accidental or incidental). It is not 
to be confused by the maternal mortality rate, which is the number of deaths (direct 
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and indirect) in a given period per 100,000 women of reproductive age during the 
same time period [1–3].
The regional MMRs for the year 2015 ranged from 11 to 14 for developed regions 
to 511–652 for sub-Saharan Africa [4].
In a study that estimated the MMR (maternal deaths per 100,000 live births) 
among Jordanian women aged between 15 and 49 years, there were 76 maternal 
deaths out of 397,588 live births. The MMR being 19.1. Of these, 43 (56.6%) deaths 
were caused by hemorrhage, thrombosis, and sepsis [5].
In this same study, avoidable deaths were found in 53.9% of the dead women, 
52.6% had substandard care, and 31.5% were poor hospital attenders, having had 
three or less antenatal visits [5].
Regarding family planning, less than one third of the 76 dead women had ever 
used any form of contraception [5].
2. Epidemiology
The incidence of venous thromboembolism (VTE) is 1–2 per 1000 pregnancies. 
In the antenatal period, there is a fivefold higher incidence than nonpregnant women 
of same age, with deep venous thrombosis (DVT) being more common. In the 
postnatal period, there is a 20-fold higher incidence, with pulmonary embolism (PE) 
being more common. Therefore, VTE is considered as one of the leading causes of 
pregnancy-related deaths [6–10].
3. Pathophysiology
The German physician, anthropologist, pathologist, prehistorian, and “father of 
modern pathology,” Rudolf Virchow (1821–1902), postulated a triad to explain the 
pathophysiology of the increased incidence of VTE in pregnancy, as follows [11]:
1. Compression of Lt iliac vein by Rt iliac artery or ovarian artery, with 90% 
DVT on left (vs. 55% nonpregnant), and 70% in iliofemoral veins (vs. 9% 
nonpregnant)
2. Hypercoagulability
• Increased clotting factors V, VII, VIII, X, VWf, and fibrinogen
• Increased resistance to protein C
• Decreased protein S activity
• Increased levels of fibrinolytic inhibitors via decreased tissue plasminogen 
activators and increased plasminogen activator inhibitors
• Acquired antithrombin III deficiency
3. Endothelial injury
• Compression by the uterus (and edema)
• Vascular damage during delivery
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There are identifiable risk factors in numerous fatal and nonfatal cases of PE in 
relation to VTE in pregnancy and puerperium. Therefore, there is a need for risk 
stratification to determine pharmacological thromboprophylaxis [12].
The risk assessment may be conducted in early pregnancy or prepregnancy at 
antenatal clinics, at admission to hospital for any reason, intrapartum and immediately 
postpartum [13].
Hypercoagulability or prothrombotic states increase the risk of thrombosis. 
Pathologies of this kind are found in a large proportion of women who report one or 
more episodes of hypercoagulability, such as lower limb or pelvic vein thrombosis, 
especially when these occur without being provoked by other conditions. A significant 
number of women have a detectable thrombotic abnormality, where the majority would 
develop VTE that is related to one or more additional prothrombotic risk factors [13].
4. History
Following the description of the development of thrombosis in 1856 by 
Virchow, antithrombin deficiency was described in 1965 by Norwegian hema-
tologist Egeberg [14]. Researchers from the Scripps Research Institute described 
protein C deficiency in 1981 [15]. Researchers at the University of Oklahoma 
described protein S deficiency in 1984 [16–18].
Graham Hughes, British rheumatologist, described antiphospholipid syn-
drome 1980s after the finding of antibodies that were associated with SLE and 
thrombosis [19].
In the 1990s, more studies described genetic thrombophilias and resistance to 
activated protein C. In 1994, researchers from Leiden, the Netherlands, described 
a mutation that affected factor V, which made it resistant to activated protein C. 
Being a genetic defect, it was named factor V Leiden mutation, after its place of 
discovery [20]. This was followed by the discovery of prothrombin gene mutation 
by the same group. This mutation results in an increase in prothrombin levels, 
which may result in some thrombotic episodes [21].
Studies of the human genome and minor gene changes are likely to reveal more 
genetic abnormalities in cases of hereditary thrombosis [16, 17].
5. Thrombophilia classification
Thrombophilia can be congenital or acquired. Congenital thrombophilia refers 
to hereditary conditions that increase the tendency to develop thrombosis, while 
acquired thrombophilia arise later in life [22–24]. The types of thrombophilia are:
Inherited thrombophilias
• Factor V Leiden mutation
• Prothrombin C 20210 mutation (PTM)
• Antithrombin III deficiency
• Protein S deficiency
• Protein C deficiency
• MTHFR mutation (homocysteine)
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Acquired thrombophilias - Antiphospholipid syndrome
• Anticardiolipin antibodies
• Lupus anticoagulant antibodies
• Anti β2 glycoprotein 1 antibodies
Thrombophilia is divided into two groups according to risk types:
High risk
• Factor V Leiden mutation, homozygous
• Prothrombin C 20210 mutation, homozygous
• Antithrombin III deficiency
• Antiphospholipid syndrome
Low risk
• Factor V Leiden mutation, heterozygous
• Prothrombin C 20210 mutation, heterozygous
• Protein S deficiency
• Protein C deficiency
Most thrombophilias have no specific therapy, but when thrombosis is recurrent, 
long-term prophylactic anticoagulation is necessary [22–24].
In general, thrombophilia testing is required for women with history of idiopathic 
or recurrent episodes of VTE, in addition to women with history of thrombophilia in 
a first-degree relative [25–28].
6. Risk factors
The risk factors for VTE are:
• Thrombophilia
• Parity of three children or more
• Major orthopedic surgery
• Lower-extremity paralysis due to spinal cord injury
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• Medical comorbidities, for example, cancer, heart failure, SLE, nephrotic 




• Gross varicose veins
• Age, if older than 35









• Hyperemesis and dehydration
• Ovarian hyperstimulation syndrome (OHSS)
• Immobility, such as hospitalization and during long travel
• Oral contraceptives or estrogen treatment for menopause symptoms
• Family history of VTE, especially in a first-degree relative
• Physical inactivity
7. Thromboembolic risk profile
Women who are pregnant or have just had a baby are at greater risk of developing 
a blood clot. The risk is greater in the presence of other factors. A score is given to 
each risk factor as follows:
• Previous VTE (except a single event related to major surgery) = 4
• Previous VTE provoked by major surgery = 3
• Known high-risk thrombophilia = 3
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• Medical comorbidities = 3
• Obesity BMI ≥ 30 = 1; BMI ≥ 40 = 2
• Cesarean section in labor = 2
• Any surgical procedure in pregnancy or puerperium except immediate repair 
of the perineum + = 3
• Hyperemesis =3
• OHSS (first trimester only) = 4
• Any other = 1
8. Thromboprophylaxis
Prophylaxis is administered according to the risk assessment’s total score as 
follows:
• ≥4 antenatal: prophylaxis from first trimester and puerperium
• 3 antenatal: prophylaxis from 28 weeks and puerperium
• ≥2 postnatal: prophylaxis for at least 10 days
There should be a lower postnatal threshold for prophylaxis than antenatally as 
risk per day is higher and duration of risk is shorter.
Women with antithrombin deficiency are often on long term oral anticoagulants, 
and extra advice is necessary as follows:
• Prophylaxis with a higher dose of low molecular weight heparin (LMWH) 
antenatally and 6 weeks postpartum or until return to oral therapy
• Anti-Xa monitoring (4-h peak levels 0.5–1.0 iu/ml)
• Possible antithrombin therapy at start of labor or prior to cesarean  
section (CS)
Women with previous recurrent VTE need extra advice as follows:
• Higher doses of LMWH
• If on long-term warfarin or other oral anticoagulants
 ○ Counsel about the risks to the fetus
 ○ Stop oral therapy, change to LMWH, within 2 weeks of the missed period 
and before the sixth week of pregnancy
• Not on oral anticoagulants: LMWH as soon as pregnancy test is +ve
9
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There are other first trimester risk factors for VTE that include:
• Women with hyperemesis should be considered for prophylaxis with LMWH. 
Discontinue when it resolves
• Women with OHSS need prophylaxis with LMWH in the first trimester
• In vitro fertilization pregnancy and three other risk factors need prophylaxis, 
with LMWH starting in the first trimester
Thromboprophylaxis should be interrupted for delivery in the case of any 
vaginal bleeding or labor, no further LMWH is administered [13].
When regional anesthetic techniques are considered, the following should be 
implemented:
• Avoid for 12 h after the previous prophylactic dose of LMWH
• No LMWH for 4 h after spinal or after epidural catheter removal
• No catheter removal for 12 h of injection
• If on a therapeutic LMWH, it should be avoided for 24 h after the last dose
With regard to prophylaxis in labor and delivery:
• Women on antenatal LMWH having an elective CS should receive prophylactic 
LMWH on the day prior to CS
• The morning dose on CS day should be omitted, the operation should take 
place that morning
• The first prophylactic dose of LMWH should be given 4–6 h after vaginal  
delivery, 6–12 h after CS (if no postpartum hemorrhage or regional 
anesthesia)
• Women with previous VTE and postpartum thromboprophylaxis should 
receive LMWH or warfarin for at least 6 weeks regardless of mode of delivery
• Women that undergo emergency CS should receive cover with LMWH for 
10 days. The same applies for elective CS in the presence of additional risk 
factors
With regard to LMWH:
• It is the agent of choice for antenatal and postnatal prophylaxis
• For prophylaxis, the doses based on booking or most recent weight
• Platelet count needs monitoring only if prior exposure to unfractionated 
heparin (UFH)
• No need for monitoring of anti-Xa levels if LMWH is for prophylaxis
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• LMWH should be reduced in renal impairment
• LMWH is safe in breastfeeding
Unfractionated heparin should be considered in cases of very high risk of 
thrombosis, and an increased risk of hemorrhage, UFH may be used peripartum, 
especially if regional anesthetic may be required. If UFH is used, platelet count 
should be monitored every 2–3 days from days 4–14 or until UFH is stopped [13].
The molecular weight (MW) of natural heparin is 5000–40,000 Daltons. The 
MWH is less than 8000 Daltons. The half-life of UFH is 1–2 h, whereas LMWH is 4–8 h.
Danaparoid and fondaparinux are used only when heparins cannot be used 
due to heparin induced thrombocytopenia or a skin allergy and perhaps should be 
prescribed by a hematologist with expertise in hemostasis in pregnancy. Regional 
anesthesia is to be avoided because of 24-h half-life [13].
Low-dose aspirin is not recommended for thromboprophylaxis in obstetric 
patients [13].
Dextran should be avoided antenatally and intrapartum because it is less effective 
than LMWH, increases the risk of bleeding and anaphylaxis that has been associated 
with uterine hypertonus, fetal distress, fetal neurological abnormalities, and fetal 
death [13].
Oral thrombin and Xa inhibitors are non-vitamin K antagonist oral anticoagulants 
(NOACs) that should be avoided in pregnant women and are not currently recom-
mended in breastfeeding [13].
Warfarin crosses placenta. If used between 6 and 12 weeks, there is a dose-
dependent risk of embryopathy, as 5% of fetuses develop nasal bridge hypoplasia, 
heart defects, vetriculomegaly, agenesis of corpus callosum, and stippled epiphysis. 
In addition, it is associated with an increased incidence of spontaneous miscarriage, 
stillbirth, neurological problems, and fetal and maternal hemorrhage. Its use in preg-
nancy is restricted to women with mechanical heart valves. It is safe in breastfeeding, 
and may convert from LMWH to warfarin postpartum when risk of hemorrhage is 
low, 5–7 days after delivery [13].
The suggested daily thromboprophylactic doses for antenatal and postnatal 
LMWH are weight dependent. For the average weight of 50–90 kg, the doses of 
enoxaparin, dalteparin and tinzaparin are 20 mg, 2500 and 3500 iu, respectively.
Contraindications to LMWH are the following:
• Known bleeding disorder
• Previous or current allergic reactions
• Active antenatal or postpartum bleeding
• High risk of major hemorrhage
• Thrombocytopenia <75 × 109/l
• Acute stroke in previous 4 weeks
• Severe renal or liver disease
• Uncontrolled hypertension
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9. Acute management of VTE
Diagnosis of acute VTE requires high index of suspicion. Its symptoms and 
signs are:
• Leg pain and swelling, usually unilateral
• Lower abdominal pain
• PE: dyspnea, chest pain, hemoptysis and collapse
• Low-grade pyrexia and leukocytosis can occur
The symptoms or signs of VTE require objective testing and treatment with 
LMWH expeditiously. If DVT remains untreated, 20% will develop pulmonary 
embolism (PE), which, in pregnancy is fatal in 15%, and in 66% of these, death will 
result within 30 min of the embolic event [13], that is, there are three deaths per 
100 DVTs.
The investigations for suspected DVT include compression duplex ultrasound, 
CBC, coagulation screen, kidney, and liver function tests. D-dimer and thrombo-
philia screen are not recommended prior to therapy [13].
The following is recommended in the initial anticoagulant treatment of VTE in 
pregnancy:
• Clinically suspected DVT or PE, LMWH immediately until the diagnosis is 
excluded by objective testing, unless strongly contraindicated
• LMWHs are not associated with an increased risk of severe PPH
• Lower risk of heparin-induced osteoporosis with LMWH versus UFHs
• LMWH titrated against booking or early pregnancy weight. Insufficient 
evidence for once daily or in two divided doses
• No routine peak anti-Xa activity of LMWH except in weight < 50 kg 
and > 90 kg or with renal impairment or recurrent VTE
• Routine platelet count monitoring should not be carried out
• Initial management of DVT, leg elevation, and a graduated elastic compression 
stocking. Mobilization with graduated elastic compression stockings
• Temporary IVC filter peripartum for patients with iliac vein VTE to reduce the 
risk of PE or recurrent PE despite adequate anticoagulation
• Therapeutic doses of subcutaneous LMWH for the remainder of pregnancy 
and for at least 6 weeks postnatally and for at least 3 months of treatment in 
total
• Because of their adverse effects on the fetus, warfarin should not be used for 
antenatal VTE treatment
Family Planning and Reproductive Health
10
• LMWH should be reduced in renal impairment
• LMWH is safe in breastfeeding
Unfractionated heparin should be considered in cases of very high risk of 
thrombosis, and an increased risk of hemorrhage, UFH may be used peripartum, 
especially if regional anesthetic may be required. If UFH is used, platelet count 
should be monitored every 2–3 days from days 4–14 or until UFH is stopped [13].
The molecular weight (MW) of natural heparin is 5000–40,000 Daltons. The 
MWH is less than 8000 Daltons. The half-life of UFH is 1–2 h, whereas LMWH is 4–8 h.
Danaparoid and fondaparinux are used only when heparins cannot be used 
due to heparin induced thrombocytopenia or a skin allergy and perhaps should be 
prescribed by a hematologist with expertise in hemostasis in pregnancy. Regional 
anesthesia is to be avoided because of 24-h half-life [13].
Low-dose aspirin is not recommended for thromboprophylaxis in obstetric 
patients [13].
Dextran should be avoided antenatally and intrapartum because it is less effective 
than LMWH, increases the risk of bleeding and anaphylaxis that has been associated 
with uterine hypertonus, fetal distress, fetal neurological abnormalities, and fetal 
death [13].
Oral thrombin and Xa inhibitors are non-vitamin K antagonist oral anticoagulants 
(NOACs) that should be avoided in pregnant women and are not currently recom-
mended in breastfeeding [13].
Warfarin crosses placenta. If used between 6 and 12 weeks, there is a dose-
dependent risk of embryopathy, as 5% of fetuses develop nasal bridge hypoplasia, 
heart defects, vetriculomegaly, agenesis of corpus callosum, and stippled epiphysis. 
In addition, it is associated with an increased incidence of spontaneous miscarriage, 
stillbirth, neurological problems, and fetal and maternal hemorrhage. Its use in preg-
nancy is restricted to women with mechanical heart valves. It is safe in breastfeeding, 
and may convert from LMWH to warfarin postpartum when risk of hemorrhage is 
low, 5–7 days after delivery [13].
The suggested daily thromboprophylactic doses for antenatal and postnatal 
LMWH are weight dependent. For the average weight of 50–90 kg, the doses of 
enoxaparin, dalteparin and tinzaparin are 20 mg, 2500 and 3500 iu, respectively.
Contraindications to LMWH are the following:
• Known bleeding disorder
• Previous or current allergic reactions
• Active antenatal or postpartum bleeding
• High risk of major hemorrhage
• Thrombocytopenia <75 × 109/l
• Acute stroke in previous 4 weeks
• Severe renal or liver disease
• Uncontrolled hypertension
11
Venous Thromboembolism in the Context of Reproduction: The Royal College of Obstetricians…
DOI: http://dx.doi.org/10.5772/intechopen.93724
9. Acute management of VTE
Diagnosis of acute VTE requires high index of suspicion. Its symptoms and 
signs are:
• Leg pain and swelling, usually unilateral
• Lower abdominal pain
• PE: dyspnea, chest pain, hemoptysis and collapse
• Low-grade pyrexia and leukocytosis can occur
The symptoms or signs of VTE require objective testing and treatment with 
LMWH expeditiously. If DVT remains untreated, 20% will develop pulmonary 
embolism (PE), which, in pregnancy is fatal in 15%, and in 66% of these, death will 
result within 30 min of the embolic event [13], that is, there are three deaths per 
100 DVTs.
The investigations for suspected DVT include compression duplex ultrasound, 
CBC, coagulation screen, kidney, and liver function tests. D-dimer and thrombo-
philia screen are not recommended prior to therapy [13].
The following is recommended in the initial anticoagulant treatment of VTE in 
pregnancy:
• Clinically suspected DVT or PE, LMWH immediately until the diagnosis is 
excluded by objective testing, unless strongly contraindicated
• LMWHs are not associated with an increased risk of severe PPH
• Lower risk of heparin-induced osteoporosis with LMWH versus UFHs
• LMWH titrated against booking or early pregnancy weight. Insufficient 
evidence for once daily or in two divided doses
• No routine peak anti-Xa activity of LMWH except in weight < 50 kg 
and > 90 kg or with renal impairment or recurrent VTE
• Routine platelet count monitoring should not be carried out
• Initial management of DVT, leg elevation, and a graduated elastic compression 
stocking. Mobilization with graduated elastic compression stockings
• Temporary IVC filter peripartum for patients with iliac vein VTE to reduce the 
risk of PE or recurrent PE despite adequate anticoagulation
• Therapeutic doses of subcutaneous LMWH for the remainder of pregnancy 
and for at least 6 weeks postnatally and for at least 3 months of treatment in 
total
• Because of their adverse effects on the fetus, warfarin should not be used for 
antenatal VTE treatment
Family Planning and Reproductive Health
12
With regard to anticoagulation during labor and delivery, the following 
should apply:
• VTE at term: consider IV UFH, more easily manipulated
• If on LMWH for maintenance and in early labor, no further heparin
• Planned elective CS or induction of labor, discontinue LMWH maintenance 
24 h in advance
• No regional anesthesia or analgesia for 24 h after therapeutic LMWH dose
• No LMWH for 4 h after spinal anesthesia or after epidural catheter removal. 
No epidural catheter removal within 12 h of the most recent injection
The initial daily therapeutic doses of enoxaparin, dalteparin, and tinzaparin are 
weight dependent, their initial doses for the average women between 50 and 90 kg 
are 60 mg twice daily or 90 mg once daily, 6000 iu twice daily or 1200 iu once daily, 
175 iu/kg once daily, respectively [13].
For anticoagulated patients undergoing CS, the following is recommended:
• If therapeutic doses of LMWH: wound drains (abdominal and rectus sheath) 
at CS. Skin closure with interrupted sutures for drainage of any hematoma
• Women at high risk of hemorrhage, in whom continued heparin is considered 
essential, manage with IV UFH until the risk factors for hemorrhage resolve
The regimen for the IV UFH is:
• Loading dose of 80 u/kg, followed by a continuous IV infusion of 18 u/kg/h
• In case of thrombolysis, omit loading dose and infusion starts at 18 u/kg/h
• Mandatory APTT 4–6 h after loading dose, 6 h after dose change, then daily 
when in therapeutic range. The target is 1.5–2.5 X control value
• The infusion rate should be adjusted according to the APTT
To monitor heparin therapy in pregnancy, routine measurement of peak anti-
Xa activity of LMWH for acute VTE, if body weight is less than 50 and more than 
90 kg, in renal impairment or recurrent VTE is required. Postoperative women 
receiving UFH should have platelet count every 2–3 days until heparin is stopped. 
Women are taught to self-inject LMWH and to safely dispose needles etc. [13].
In cases of acute PE, CXR, compression duplex ultrasound and ECG should 
be performed. ECG may show “S1Q3T3” pattern (large S wave in lead I, Q wave in 
lead III, and inverted T wave in lead III), Rt BBB, M wave V1 and broad S V6, due to 
acute right heart strain [13].
If DVT is present, no further investigations are required, and treatment should 
continue [13].
In suspected PE without symptoms and signs of DVT, CT pulmonary angio-
gram or V/Q lung scan should be performed. If CXR is abnormal with suspicion of 
PE, CTPA is better than V/Q scan. In cases of normal ventilation with multiple seg-
mental perfusion deficits, the probability of PE is 80%. There is a slightly increased 
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risk of childhood Ca but lower risk of maternal breast Ca than CTPA. The absolute 
risk is very small in both [13].
Anticoagulation should be continued until PE is definitively excluded [13].
In acute PE, it is recommended that:
• Shocked women who are pregnant or in the puerperium are managed 
individually regarding IV UFH, thrombolytic therapy or thoracotomy and 
embolectomy
• Multidisciplinary involvement of senior physicians, obstetricians, surgeons, 
and radiologists
• IV UFH is preferred in massive PE with cardiovascular compromise
• Urgent portable ECG or CTPA within 1 h of presentation. Immediate throm-
bolysis should be considered
• Maternal resuscitation as per immediate life support. Cardiopulmonary 
resuscitation in a left lateral tilt. Perimortem CS by 5 min if resuscitation is 
unsuccessful and the pregnancy is more than 20 weeks
10. Key points
• LMWH is the agent of choice for antenatal prophylaxis
• Score ≥ 4 antenatal: prophylaxis in first trimester and 6 weeks postnatally
• Score = 3 antenatal: prophylaxis from 28 weeks and 6 weeks postnatally
• Score ≥ 2 postnatal: prophylaxis for a minimum of 10 days
• Women on antenatal prophylaxis are for postnatal prophylaxis for 6 weeks
• Women with symptoms or signs of VTE should have LMWH until the diagnosis 
is excluded by objective testing, unless strongly contraindicated
• All women should undergo a documented thromboembolic risk profile for VTE 
before conception and in early pregnancy
• The documented thromboembolic risk profile should be repeated if admission 
to hospital is required or if an intercurrent medical condition does occur
• A repetition of the thromboembolic risk profile is required intrapartum and in 
the immediate postpartum period
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The Role of Information 




Freedom is needed in family planning and in the decision on how many children 
the couple will have, not to be influenced by a third person, political situations, or 
religious conviction. There is a need for information, education, and communica-
tion about possibilities in natural family planning, in order to be able to choose the 
right way, because there are many options even without side effects. Nowadays, we 
can add to these traditional possibilities of natural family planning also informa-
tion technologies and electronic devices, which are increasingly available to a large 
portion of the population. Their reliability, with correct usage, is comparable to 
the barrier methods and in some cases to hormonal contraceptive methods. Next 
development of these devices can more increase their reliability. Of course, the 
active approach of users is needed.
Keywords: natural family planning, basal body temperature, cervical mucus, 
symptothermal method, information technologies, electronic devices, digitized 
records, application, evaluation, reliability, price
1. Introduction
“Natural family planning (NFP) is a term used to describe methods of planning 
or preventing pregnancy based on observation of naturally occurring signs and 
symptoms of the fertile and infertile phases of the menstrual cycle. People who 
use NFP to avoid or delay pregnancy abstain from intercourse on potentially fertile 
days. Those wanting to achieve pregnancy use NFP to identify the fertile phase and 
hence maximize the probability of pregnancy. Techniques include the basal body 
temperature method, the cervical mucus (Billings’) method, the symptothermal 
method, and the calendar or rhythm method (Ogino-Knaus). It is important to note 
that NFP is not a method of contraception but rather a technique for determining 
the fertile period; abstinence during this period is what prevents pregnancy. The 
methods are thus likely to be of interest to people who, for any reason, do not wish 
to use mechanical or pharmacological contraceptives” [1]. This is the definition 
given by the World Health Organization in their publication about NFP. To this defi-
nition, some additional notes have to be added: NFP is a manifestation of a respon-
sible attitude towards family and own health, and it helps a woman to know how 
her body works, which has many benefits not only in family planning. The human 
body is the complex sensitive system. If the woman knows her own body and 
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makes regular self-monitoring, she knows when everything is alright and when it is 
needed to seek expert help. We must not forget either the psychological side of NFP, 
because the intercourse is not only a physiological act but it influences an individu-
al’s psychological state or soul and a mutual relationship, especially in marriage. If 
both partners identify the use of NFP methods, this strengthens their mutual bond. 
The use of these methods is becoming a lifestyle. No known side effects and no 
external factors that affect or damage this sophisticated, naturally designed fertility 
mechanism are also a benefit. The disadvantages include more demanding, but not 
impossible, use during nonstandard situations such as breastfeeding, menopause, 
the medications affecting the menstrual cycle, previous contraception use,  and 
irregular cycles. The solution of some disadvantages and increase in the comfort 
of using NFP methods bring information technologies in the form of electronic 
devices and applications.
2. Natural family planning methods
Natural family planning methods are those that don’t use a chemical or mechani-
cal contraceptive. The basis of their use is the observation of fertility symptoms and 
determination of fertile and infertile windows and periodical abstinence practice. 
Each method uses another symptom singly or a combination of symptoms.
2.1 Cervical mucus method
This method is known as the Billings Ovulation Method (BOM). The method is 
based on the observation of the structure and density of cervical mucus. Cervical 
mucus is a normal, healthy secretion of the cervix formed by the effects of estro-
gen hormones, usually appears on the genitals a few days before ovulation and at 
the time of ovulation, and is usually lost after ovulation. The cervical mucus is a 
very positive sign of fertility as it provides the sperm with nutrition and a suitable 
environment for movement. Observations are indicated in Figure 1 to obtain an 
accurate record of the course of the cycle and the onset of fertile days. The method 
has four rules: three preovulatory rules and one after ovulation rule—the rule of 
the peak. Method requirements are an accurate observation, accurate records, and 
motivation and cooperation of the couple. By following the rules of the method to 
delayed conception, efficiency is greater than 99% [1]. Another modification of this 
cervical mucus method is Creighton Model FertilityCare System (CrMS); however, 
it uses a different picture dictionary (PD) and standardized terminology. CrMS 
forms the basis for Natural Procreative Technology (NaProTECHNOLOGY) suc-
cessfully used for achieving pregnancy in infertility problems and miscarriage. In 
addition, NaProTECHNOLOGY uses a series of sonographic examinations during 
different parts of the cycle and repeated blood tests to identify the causes of infer-
tility. The main idea of this type of infertility treatment is a minimal intervention in 
the female cycle and the effort to avoid hormonal stimulation or in vitro fertiliza-
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2.2 Basal temperature method
Basal body temperature (BBT) is the temperature of a relaxed human body 
measured in a moment after waking up after a minimum of 6 h of night sleep, unaf-
fected by food, drink, or physical exertion. After ovulation, the ruptured follicle 
becomes a yellow corpus luteum and begins to produce the hormone progesterone, 
which causes a postovulatory increase in BBT. This ascension lasts until the next 
menstruation. Two-level temperature curves are therefore typical for a healthy 
fertile woman, as shown in Figure 2. There are precise rules to record the tempera-
ture curve; temperature is measured to a minimum of two decimal places. The BBT 
shift typically occurs 1 day after the day of ovulation, so the fertile phase can be 
determined 5 days before the temperature shift and 2 days after it. This calculation 
of fertile window includes twofold ovulation and sperm life span. Approximately 
1 day before ovulation, a decrease of BBT can be observed typically [3].
2.3 Symptothermal method
The combination of both previous methods, cervical mucus and basal tempera-
ture method, is the symptothermal method that was developed by Austrian Dr. 
Josef Rötzer [4]. As the name itself suggests, the method used to menstrual cycle 
evaluation basal body temperature and symptoms of fertility, viz., cervical mucus 
and cervix changes. Another symptom can be used too, e.g., breast tenderness and 
lower abdominal pain. All observed fertile symptoms are recorded in special record 
table and evaluated by 11 rules—4 rules for specifying infertility before ovulation 
and 7 rules for specifying postovulatory infertility. For evaluating one cycle, it is not 
needed to use every rule. The most appropriate rule applies. The reliability of the 
method was determined by the Pearl Index, PI 0.4 [5, 6].
2.4 Calendar/rhythm method
The calendar method (sometimes called the Ogino-Knaus method) assumes 
that a woman will have a regular menstrual cycle. The observed symptom is only 
the first day of menstruation. From the length of the previous cycles (shortest and 
longest), it determines the beginning and end of the fertile period of the following 
cycle according to certain rules (each author states slightly different rules). This 
method is obsolete and unreliable mainly for irregular cycles. Pearl Index of this 
method was estimated on 18.5 + 1.8 [7].
Figure 2. 
BBT records.
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The successful use of NFP methods clearly involves a thorough study of the rules 
of a particular method and their consistent adherence. The success rate decreases 
significantly with careless use and application of the rules. Human factor failure 
is the most common cause of an unplanned pregnancy. Therefore, there are many 
books, courses, and professional teacher pairs, with a certificate for each method, 
that teach the rules of using NFP methods and usually offer free evaluation support 
of fertility symptoms. The practical experience of teacher couples using a particular 
method is very helpful.
3. Information technologies and electronic devices
New technologies are also entering NFP. There is a hope that it will make it 
possible to reduce the length of the required abstinence to the necessary time. These 
include, in the first place, devices for measuring hormone levels in the urine (e.g., 
Persona, ClearBlue Easy Fertility Monitor). The preliminary results of their testing 
in practice are encouraging, but their effectiveness has not yet exceeded the level 
achieved by the symptothermal method. There are also minicomputers that mea-
sure and evaluate the basal body temperature (e.g., Lady-Comp, Daysy, iFertracker, 
OvuSense) or the temperature and luteinizing hormone content in the urine and 
cervical mucus (Cyclotest myWay). Their advantage is that the woman does not 
have to keep records because they are stored in the computer memory but otherwise 
in principle do not differ from the temperature method. Miniature microscopes for 
monitoring saliva crystallization (e.g., Lady Q ) have proven unreliable and can only 
be recommended to couples who wish to conceive.
3.1 Cyclotest myWay
For evaluating fertile days by Cyclotest (Figure 3) the basis is the measurement 
of the basal body temperature. For increasing the safety of this device, the two 
fertile symptoms can be included—ovulation test or quality of cervical mucus. The 
cycle computers follow exactly the symptothermal methodology. Even an irregular 
cycle that is still within the normal range can be reliably evaluated, and it is possible 
to record the cycle length from 23 to 45 days. When irregularities occur, the tem-
perature should not be measured. Alternatively, continue measuring and manually 
note the results for that particular day as a disruption. After pregnancy the device 
can be used as soon as the menstruation is regular again and woman is not nursing 
at night.
The cycles can be saved as a PDF file via Cyclotest mySoftware, the software 
comes for free. The computer alerts of possible ovarian insufficiency in the last 
Figure 3. 
Cyclotest myWay device and information on screen [8].
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12 cycles are stored and offer additional function skincare, which shows what type 
of cream is most applicable for which days of the cycle. The settings can be switched 
between the two modes—child planning and cycle control. One computer can be 
used for two objectives. In the child planning mode, the following additional func-
tions will be activated:
• Indication of possible luteal phase deficiency
• Pregnancy display
• Birth planner
• Display of the highly fertile days
Apart from that, the menu only differs in coloration. In the “child planning” 
mode, the dominant color is magenta, and in the “cycle control” mode, it is violet. 
The price of these devices on the manufacturer’s website is $ 333, and replacement 
of measuring probe costs $ 56. In terms of reliability, manufacturers refers to the 
reliability of the symptothermal method; they do not specify reliability in percent-
age or Pearl Index for this device especially [8].
3.2 Lady-Comp
Lady-Comp is an intelligent fertility tracker/minicomputer designed to deter-
mine fertile and infertile days by morning BBT in the mouth 60 s every morning. 
The Lady-Comp works on the basis of more than 1 million cycles with statistical 
data to determine fertile and infertile days, with an accuracy of 99.3% [9], and 
the day of ovulation. Lady-Comp observes the individual cycle and determines 
fertility for the next 24 h. It correctly evaluates complicated and irregular cycles 
and identifies and eliminates unlikely temperature measurements, e.g., fever. 
The device displays temperature, menstruation, fertility: red, fertile day; green, 
infertile day; and yellow, learning phase or uncertainty. It offers the possibility 
to write personal data into the calendar, download and print raw data or upload 
it into the website, and get a full analysis of cycle, all averages, and a lot of 
interesting charts and graphs. Lady-Comp can be upgraded to Lady-Comp Baby, 
which works with over 5 million cycle data and has extra features to plan a baby 
naturally:
• CLI (low corpus luteum function)
• Forecast hits for 20 cycles
• Documentation of intercourse
• Indication of possible pregnancy after 4–5 days
• Indication of probable pregnancy after 15 days
• Conception date and birth date
Pearly is a simpler and less expensive solution from the same manufacturer. 
Pearly is a pocket-size fertility tracker working on the same way as Lady-Comp; 
however, it has fewer functions. Fertility status is evaluated via color lights, as 
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Pearly is a simpler and less expensive solution from the same manufacturer. 
Pearly is a pocket-size fertility tracker working on the same way as Lady-Comp; 
however, it has fewer functions. Fertility status is evaluated via color lights, as 
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well as in Lady-Comp (Figure 4). The price of these devices ranges from $ 375 
for Pearly, $ 455 for Lady-Comp to $ 545 for Lady-Comp Baby. Replacement of 
measuring probe costs $ 56 [11].
3.3 Daysy
Daysy uses the same evaluating algorithm as Lady-Comp and has the same 
reliability of 99.3%. Thermometer with accuracy 0.01°C records the BBT every 
morning in 60 s. The device itself does not have a display; it has only one activa-
tion button and three control lights. Information about fertility are separate—past 
data are only in the phone app, and actual fertility status is displayed in the device 
as color light. Daysy (Figure 5) is CE certified and is a Class I medical device. It 
has exceptional design and appearance, but for more detailed information, it is 
necessary to use the mobile application. The manufacturer’s price is $ 333, and the 




(a) Lady-Comp, (b) Lady-Comp baby, and (c) Pearly [10].
25
The Role of Information Technologies in Natural Family Planning
DOI: http://dx.doi.org/10.5772/intechopen.92136
3.4 iFertracker
The iFertracker is applicable for both the fertility awareness method (FAM) and 
the symptothermal method of natural family planning. The device itself is actually 
a thermometer that captures core temperature opposed to the skin or environmen-
tal temperature which is stuck to the armpit by means of double-sided medical tape. 
iFertracker monitors temperature continuously overnight and collects 20,000 data 
points with an accuracy of 0.01°C in a single night. The device identifies invalid 
data, such as getting up in the middle of the night, and works around different 
sleeping schedules to provide flexibility without disturbing the integrity of data. 
It is necessary to send data from the thermometer to the mobile app every morn-
ing via Bluetooth. The application automatically charts data and provides a daily 
fertility snapshot. The application also offers notifications for when the pair should 
try to conceive and allows exporting the BBT chart from directly within the app. 
The manufacturer recommends keeping track of factors like sexual activity, stress, 
cervical mucus quality, and sleep to increase the accuracy of ovulation prediction. 
Change in these habits can cause natural BBT fluctuation and impact the menstrual 
cycle. The cost of iFertracker and 90 double-sided adhesive patches is $ 129.00, 60 
pieces of replacement disposable medical patches cost $ 14.99, and the application 
is for free. The manufacturer does not report reliability or any scientific studies on 
their product [14].
On the market other thermometers are also available which measure continu-
ous core body temperature (CCBT) on the shoulder or on the wrist like a watch 
(Termdrop, Ava bracelet) or in the ear (YONO); the hiMAMA monitor works on 
a similar principle to iFertracker but has a lower purchase price and does not use 
disposable patches. Although they offer many additional measurements such as 
heart rate or respiratory rate, their reliability could be much discussed as they do 
not measure basal body core temperature. Their applicability is often limited to 
regular cycles (Figure 6).
3.5 OvuSense
OvuSense is a fully certified medical device, clinically proven in over 
50,000 cycles of use. It measures core body temperature using a specially designed 
vaginal sensor, which is used overnight only, and data are downloaded to the 
dedicated OvuSense app each morning (Figure 7). OvuSense provides live updates 
Figure 6. 
iFertracker thermometer [15].
Family Planning and Reproductive Health
24
well as in Lady-Comp (Figure 4). The price of these devices ranges from $ 375 
for Pearly, $ 455 for Lady-Comp to $ 545 for Lady-Comp Baby. Replacement of 
measuring probe costs $ 56 [11].
3.3 Daysy
Daysy uses the same evaluating algorithm as Lady-Comp and has the same 
reliability of 99.3%. Thermometer with accuracy 0.01°C records the BBT every 
morning in 60 s. The device itself does not have a display; it has only one activa-
tion button and three control lights. Information about fertility are separate—past 
data are only in the phone app, and actual fertility status is displayed in the device 
as color light. Daysy (Figure 5) is CE certified and is a Class I medical device. It 
has exceptional design and appearance, but for more detailed information, it is 
necessary to use the mobile application. The manufacturer’s price is $ 333, and the 




(a) Lady-Comp, (b) Lady-Comp baby, and (c) Pearly [10].
25
The Role of Information Technologies in Natural Family Planning
DOI: http://dx.doi.org/10.5772/intechopen.92136
3.4 iFertracker
The iFertracker is applicable for both the fertility awareness method (FAM) and 
the symptothermal method of natural family planning. The device itself is actually 
a thermometer that captures core temperature opposed to the skin or environmen-
tal temperature which is stuck to the armpit by means of double-sided medical tape. 
iFertracker monitors temperature continuously overnight and collects 20,000 data 
points with an accuracy of 0.01°C in a single night. The device identifies invalid 
data, such as getting up in the middle of the night, and works around different 
sleeping schedules to provide flexibility without disturbing the integrity of data. 
It is necessary to send data from the thermometer to the mobile app every morn-
ing via Bluetooth. The application automatically charts data and provides a daily 
fertility snapshot. The application also offers notifications for when the pair should 
try to conceive and allows exporting the BBT chart from directly within the app. 
The manufacturer recommends keeping track of factors like sexual activity, stress, 
cervical mucus quality, and sleep to increase the accuracy of ovulation prediction. 
Change in these habits can cause natural BBT fluctuation and impact the menstrual 
cycle. The cost of iFertracker and 90 double-sided adhesive patches is $ 129.00, 60 
pieces of replacement disposable medical patches cost $ 14.99, and the application 
is for free. The manufacturer does not report reliability or any scientific studies on 
their product [14].
On the market other thermometers are also available which measure continu-
ous core body temperature (CCBT) on the shoulder or on the wrist like a watch 
(Termdrop, Ava bracelet) or in the ear (YONO); the hiMAMA monitor works on 
a similar principle to iFertracker but has a lower purchase price and does not use 
disposable patches. Although they offer many additional measurements such as 
heart rate or respiratory rate, their reliability could be much discussed as they do 
not measure basal body core temperature. Their applicability is often limited to 
regular cycles (Figure 6).
3.5 OvuSense
OvuSense is a fully certified medical device, clinically proven in over 
50,000 cycles of use. It measures core body temperature using a specially designed 
vaginal sensor, which is used overnight only, and data are downloaded to the 
dedicated OvuSense app each morning (Figure 7). OvuSense provides live updates 
Figure 6. 
iFertracker thermometer [15].
Family Planning and Reproductive Health
26
predicting ovulation up to 24 hours in advance using current cycle data, then 
confirming the date of ovulation. At the start of each cycle, OvuSense provides a 
full 8-day fertile window. Vaginal sensor needs to be worn for a minimum of 4 hours 
during rest or sleep. It is essential to remove the sensor before using a bathroom or 
before going to have sex. OvuSense can be used alongside fertility medications and 
procedures; it has intelligent filtering systems that remove the temperature spikes 
outside of that range which is caused by illness or other exceptional situations. It is 
a class of medical device which is tested and conforms to strict medical standards. 
The sensor is made of antibacterial medical grade silicone, simply cleaned daily 
with warm water and soap. If the woman has completely regular ovulation, the live 
prediction has a positive predictive value of 96% and accurate ovulation confirma-
tion of 99%. OvuSense Starter Pack 2-month subscription cost is $ 129 and its 
1-year subscription cost is $ 210 [15, 16].
Another device which continuously collects body temperature from inside the 
body not only at night but during the day too is Priya—an intravaginal ring—as a 
fertility sensor. The ring measures the core body temperature every 6 min and sends 
the data wirelessly to a paired smartphone for monitoring and interpretation. The 
Priya Sensor is not yet available for sale. The limited release program started in late 
2019 [17].
3.6 Persona
Persona is a diagnostic tool for home use. Persona records hormone levels (it 
measures the changes in estrogen-3-glucuronide (E3G) and luteinizing hormone 
(LH) concentrations) that accompany the ovulatory phase of the woman’s men-
strual cycle and considers the life span of sperm. The test stick captures hormones 
from morning urine, and the device then reads, records, and uses this information 
to tell you if you have a fertile day when you can get pregnant (a red light) or an 
infertile day when you cannot get pregnant (a green light) (Figure 8). The device 
determines 8 test days in each cycle, so the woman needs 8 test sticks (only in the 
Figure 7. 
OvuSense vaginal sensor and OvuSense app [17, 18].
27
The Role of Information Technologies in Natural Family Planning
DOI: http://dx.doi.org/10.5772/intechopen.92136
first cycle the test is performed 16 times). Persona cannot be used by every woman, 
specifically women:
• Who cannot accept the possibility of pregnancy associated with the use of 
Persona (reliability confirmed by independent studies is 94%)
• With a cycle of less than 23 days
• With a cycle greater than 35 days
• Who have symptoms of menopause
• Who are breastfeeding
• Who use hormonal therapy, e.g., hormonal contraception, infertility treat-
ment, hormone replacement therapy
• Who use any other treatment that affects their cycle
• Who use antibiotics containing tetracycline
• Who have reduced liver, kidney function, or polycystic ovary syndrome 
(PCOS) [18]
Persona is manufactured by SPD Swiss Precision Diagnostics GmbH in 
Switzerland. ClearBlue Easy Fertility monitor works on the same principle, but it 
is especially used to identify high-fertility days and achieve pregnancy. The price 
per Persona starts from $ 45; additional components or programs are not necessary, 
except for test sticks [19] (Figure 8).
4. Applications for natural family planning
The trends of the modern world are mobile applications; they are useful and eas-
ily available, and they can be used at any time with our mobile phone or tablet. The 
area of natural family planning did not also avoid the arrival of mobile applications. 
For the purpose of NFP, a lot of applications are available. Some offer reliable and 
quality results, but some are not recommended for use. However, all applications 
Figure 8. 
Persona device and displayed data [18, 20].
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need input data, which are obtained by measuring basal body temperature, ovula-
tion test result, or observation—the onset of menstruation, cervical mucus quality, 
etc. BBT can be measured by an ordinary thermometer with an accuracy of 0.01°C 
and enter values into the application manually. The second solution is measured 
values by digital Bluetooth basal thermometer—values are automatically written 
to the app when connected to a mobile phone, and the app also creates graphs, 
notifications, and statistical data. The following section will first describe wireless 
thermometers with custom applications and then stand-alone applications.
4.1 Cyclotest mySense
Cyclotest mySense is used to track the menstrual cycle without much effort, 
using Bluetooth technology. The basal temperature values measured each morn-
ing in 4-hour measuring window are transmitted wirelessly and directly to the 
smartphone. The thermometer is a Class IIb medical product, CE-certified, and 
thus approved for natural contraception. In the calculation of fertility, one of the 
observation data as cervical mucus quality or the result of an ovulation test (LH) 
can be included. The fertile phase is determined automatically in the application 
and offers a transparent view of the temperature curve and all additional inputs 
at all times. The application has two modes, fertility wish mode and contraception 
mode. The fertility algorithm is based on the symptothermal method and uses the 
algorithm of cyclotest myWay. The more recorded cycle the cyclotest mySense 
App has, the more accurate the forecast will be. If the measured temperature 
could be falsified by external influences, it should be excluded from the calcula-
tion directly in the application. Cyclotest mySense is suitable for cycles between 
16 and 45 days, and the luteal phase should not be less than 11 days. The cyclotest 
mySense app is available for free, and the thermometer costs $ 122 (Figure 9).
Figure 9. 
Cyclotest mySense thermometer and app [21].
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4.2 Biolight PregAid
Biolight basal thermometer is a device designed for daily temperature measure-
ment and monitoring. The thermometer is able to store measured data and transfer 
it to PregAid application. The application is able to evaluate the measured data and 
thus determine fertile and infertile days, menstruation arrival even in an irregular 
cycle, or the possibility of pregnancy. This is ideal for women who are trying to 
conceive and have an irregular cycle. The thermometer is easy to use; just turn on 
the thermometer every morning after waking up, and measure the temperature 
under tongue for 3 minutes. By turning on the application, data will be saved and 
synchronized with the cloud. The cost of the device is $ 39.
The following products can also be included in the same user and price group 
of thermometers with own application as Biolight: Ovy, Kindara thermometer, 
TempCue, Femometer, PrecisionTemp, Xiaomi Mijia, and others.
4.3 Natural cycles
The natural birth control app uses a statistical algorithm that learns a woman’s 
unique cycle from the BBT temperatures. Once Natural Cycles has analyzed the 
temperature curve, it can detect ovulation, learn fertile window, and determine the 
phase of the menstrual cycle. Natural Cycles offers a personalized fertility status 
every day. The application requires measurement of temperature at least 5 days a 
week within a 4-hour window. However, the fewer data are added, the more red 
days the app will give, hence recommending to use protection. Nature Cycles offers 
to add further data such as ovulation test results, premenstrual syndrome symp-
toms, and unprotected sex. The more data are put into the app, the more green days 
are going to get back. For irregularities as thyroid conditions, PCOS, or length of 
cycle out of range of 21–35 days, the app does not become any less effective. Natural 
Cycles is a handy tool for keeping track of irregularities in the cycle, but it gets more 
red days. The reliability declared by the manufacturer is 93% effective with typical 
use and 98% effective with perfect use (sexual abstinence or using condoms on red 
days).
Natural Cycles is in Europe the first CE-marked Class II medical device 
(CE0123) for use as a method of birth control, and in 2018 the US Food and Drug 
Administration (FDA) cleared Natural Cycles as a medical device for use as a digital 
method of birth control. The annual subscription (with thermometer) costs $ 71.76, 
and the monthly subscription costs $ 9.93 [22, 23].
4.4 OvuView
The application has no official website. Information can only be drawn from the 
Google Play Store and from the user experience or your own experience with the 
application.
OvuView offers three modes: (a) simple menstrual calendar, (b) achievement 
conception that highlights days with a high probability of pregnancy, and (c) pre-
venting pregnancy. The app displays the menstrual wheel from which the day of the 
cycle, the number of days to menstruation, the start of fertile days, and the expected 
ovulation can be read, as well as the current phase of the cycle. Standard symptoms 
such as BBT and mucus symptoms are entered into the application. However, 
optional and intrinsic symptoms, e.g., mood, weight, PMS, and ovulation test can 
be recorded. When entering the observation of mucus, more symptoms of the 
predefined options can be selected at a time. Observation of mucus and the cervix 
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is automatically rewritten into international symbols. The “Calendar” function 
displays clearly a calendar with evaluated and predicted values  of menstruation and 
fertile days. The “Graph” function displays the temperature curve along with other 
recorded symptoms. OvuView evaluates symptoms based on the following rules:
• Rule 21/20 (six cycles recorded, no mucus)
• Döring rule (six recorded cycles, mucus)
• Rule B (temperature, mucus)
• Rule R (temperature, mucus)
• Rule K (temperature, mucus)
• Rule C or O (temperature, mucus)
• Rule of 5 dry days (mucus)
• Rule of four high temperatures (temperature)
• Rule of five high temperatures (temperature),
• Marshall rule (temperature)
• Last dry day rule (mucus, six cycles recorded, min. of 5-day long mucus 
episode)
Each method indicates what symptoms it needs for the evaluation, the rule’s 
effectiveness, and the symbol, which indicates the phases can evaluate for a particu-
lar method. Each method can be switched on or off (e.g., a woman after taking a 
contraceptive can limit the evaluation only to the 5 T rule). The paid version costs $ 
5 and offers extended functionalities: marking of low-temperature level and ovula-
tion on the day when temperature increased; backup data to Google account (the 
free version can be backup to an SD card); sending data by e-mail and exporting 
graphs, password protection, widgets, own symptoms, alerts, e.g., mucus tracking, 
ovulation reminder, full picture mode, cycle management (pregnancy); removal of 
advertisements; and method selection/configuration.
To make the results as reliable as possible, OvuView offers the option to enter 
custom cycle lengths (longest and shortest) or to rely on general cycle lengths 
[24–28], which of course reduces reliability. If nothing is chosen, the application 
evaluates only based on the recorded cycles. Data can be imported from previously 
used another application.
According to the description on Google Play, the application evaluates using 
the symptothermal method as well as other methods. The description claims to be 
implementing 14 evaluating methods. In our opinion, this is a vague terminology, 
since the mentioned methods are actually the rules of the symptothermal method, 
of course, in addition to two trivial calendar calculation methods. However, it is 
not clear what precise didactic transposition of symptothermal method the app 
is. Compared to the paper form of evaluation, there are several differences in the 
electronic version. The reliability of the application depends on the accuracy and 
thoroughness of the entered data [29].
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4.5 SymptoPlus
The SymptoPlus is not a medical device but an electronic learning tool to take 
charge of fertility. Application evaluation algorithm is based on a combination of 
three NFP methods—NFP-sensiplan (symptothermal method), Billings Ovulation 
Method (cervical mucus method), and Rötzer/Northwest Family Servis (NWFS, 
the American Rötzer version, symptothermal method). SymptoPlus is not an 
exactly didactic transposition of one particular method.
This stand-alone app doesn’t require an Internet connection for its basic fea-
tures. An Internet connection is only needed for syncing to secure access, even if 
losing the phone. To verify an account, go to sympto.org. After verifying an e-mail 
address, the 15 days free of charge of personal follow-up with a symptothermal 
expert without any commitment is available. After a 15-day trial, the SymptoPlus 
must be purchased in the Google Play Store for a nominal fee. A free version is also 
available, but SymptoPlus is faster and simpler to view than SymptoFree. The app is 
available in several languages and offers an internal message box which allows the 
client to communicate directly with her adviser.
For guaranteed contraceptive effectiveness, it is needed to use the app properly 
and use Sympto for 6 months with a counsellor (Daisy PLUS) or enter six past cycles 
verified by Sympto. To interpret a cycle correctly, Sympto has defined a minimum 
of 10 crucial information in order: the beginning of the cycle which is triggered by 
the 3 red drop icons, a minimum of 4 low temperatures within 6 days to specify 
the cover line, the mucus peak day indication (2 signs), and the 3 correct high 
temperatures [24, 25] (Figure 10).
The market offers a number of similar applications, e.g., myNFP, LilyPro, 
CycleProGo, Lady Cycle, etc. Some are more functional, others are less, and some 
can be used only as a record table without evaluating or with not reliable evaluating. 
The applications for NFP have a huge potential, but thorough research is needed. 
Medical doctor, developers, expert of didactic transpositions, learning specialists, 
teacher pairs for a specific method, and women using the app should work together 
Figure 10. 
SymptoPlus application record table [26].
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5 and offers extended functionalities: marking of low-temperature level and ovula-
tion on the day when temperature increased; backup data to Google account (the 
free version can be backup to an SD card); sending data by e-mail and exporting 
graphs, password protection, widgets, own symptoms, alerts, e.g., mucus tracking, 
ovulation reminder, full picture mode, cycle management (pregnancy); removal of 
advertisements; and method selection/configuration.
To make the results as reliable as possible, OvuView offers the option to enter 
custom cycle lengths (longest and shortest) or to rely on general cycle lengths 
[24–28], which of course reduces reliability. If nothing is chosen, the application 
evaluates only based on the recorded cycles. Data can be imported from previously 
used another application.
According to the description on Google Play, the application evaluates using 
the symptothermal method as well as other methods. The description claims to be 
implementing 14 evaluating methods. In our opinion, this is a vague terminology, 
since the mentioned methods are actually the rules of the symptothermal method, 
of course, in addition to two trivial calendar calculation methods. However, it is 
not clear what precise didactic transposition of symptothermal method the app 
is. Compared to the paper form of evaluation, there are several differences in the 
electronic version. The reliability of the application depends on the accuracy and 
thoroughness of the entered data [29].
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4.5 SymptoPlus
The SymptoPlus is not a medical device but an electronic learning tool to take 
charge of fertility. Application evaluation algorithm is based on a combination of 
three NFP methods—NFP-sensiplan (symptothermal method), Billings Ovulation 
Method (cervical mucus method), and Rötzer/Northwest Family Servis (NWFS, 
the American Rötzer version, symptothermal method). SymptoPlus is not an 
exactly didactic transposition of one particular method.
This stand-alone app doesn’t require an Internet connection for its basic fea-
tures. An Internet connection is only needed for syncing to secure access, even if 
losing the phone. To verify an account, go to sympto.org. After verifying an e-mail 
address, the 15 days free of charge of personal follow-up with a symptothermal 
expert without any commitment is available. After a 15-day trial, the SymptoPlus 
must be purchased in the Google Play Store for a nominal fee. A free version is also 
available, but SymptoPlus is faster and simpler to view than SymptoFree. The app is 
available in several languages and offers an internal message box which allows the 
client to communicate directly with her adviser.
For guaranteed contraceptive effectiveness, it is needed to use the app properly 
and use Sympto for 6 months with a counsellor (Daisy PLUS) or enter six past cycles 
verified by Sympto. To interpret a cycle correctly, Sympto has defined a minimum 
of 10 crucial information in order: the beginning of the cycle which is triggered by 
the 3 red drop icons, a minimum of 4 low temperatures within 6 days to specify 
the cover line, the mucus peak day indication (2 signs), and the 3 correct high 
temperatures [24, 25] (Figure 10).
The market offers a number of similar applications, e.g., myNFP, LilyPro, 
CycleProGo, Lady Cycle, etc. Some are more functional, others are less, and some 
can be used only as a record table without evaluating or with not reliable evaluating. 
The applications for NFP have a huge potential, but thorough research is needed. 
Medical doctor, developers, expert of didactic transpositions, learning specialists, 
teacher pairs for a specific method, and women using the app should work together 
Figure 10. 
SymptoPlus application record table [26].
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to create the app. From this cooperation arise a quality application, which however 
must be subjected to in-depth testing on a sufficient number of cycles. Entered data 
must be accurate and obtained in accordance with the knowledge of symptothermal 
cycle observation.
5. SymRec
Applications and IT tools for NFP are an interesting research area, and based on 
how they were mentioned above, they have great potential. On the basis of these 
facts, we also decided to create a web site for evaluating the menstrual cycle accord-
ing to symptothermal method (STM). The IT tool SymRec is an accurate didactic 
transposition of rules of STM used in Slovakia with some restriction listed below. 
We followed the rules outlined in the book Handbook of Symptothermal Methods 
published by Couple to Couple League in Slovakia [27].
The goal of the work was to create an IT tool—electronic record table (ERT)—
similar to the printed record table used for symptothermal observation. ERT serves 
for daily data entry, storage data, and evaluating menstrual cycle according STM 
rules. Access to data is possible for every device connected to the Internet. ERT is 
available on the website: http://symrec.judak.eu/.
5.1 Didactic transposition of STM rules
Didactic transposition is the isolation of certain terms and properties from 
the environment in which they originated and their adaptation to the context in 
the new environment. In fact, it is the transfer of the regularities of the teaching 
or learning process (rules of some NFP method) from the analogue environment 
(manual paper method) to the digital environment (application, IT tool). It is an 
interpretation of NFP rules in the digital world using programming code. The origi-
nal manual STM has been transformed into an electronic version by transcription to 
PHP code. ERT evaluates the record according to these rules:
1. Evaluation of the first phase of preovulatory infertility:
• Last dry day rule
• Doctors experience rule
• Rule 20/21 days
• Döring rule
2. Evaluation of the third phase of postovulatory infertility:
• Rules R, B, and K—double-symptom rules (cervix mucus, basal body temperature)
• 4 T, 5 T, and Marshall rule—one-symptom rules (BBT)
• 5DMD—one-symptom rule (cervix mucus)
ERT expects that only valid temperatures are entered. Evaluation does not offer 
a possibility as “planning down” and averaging the temperatures, which are possible 
in manual evaluation in case of nonstandard temperature curves. To verify each 
rule, software checks at least six previous cycles and a maximum of thirteen cycles. 
According to the number of cycles in the recorded history of ERT, the evaluation is 
performed for the 8th recorded cycle, and a different evaluation rule is used for the 
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13th recorded cycle. It follows that for validation of all possibilities of evaluation, 
27 rules have to be created. For evaluation of the first phase preovulatory infertility, 
it is necessary to have recorded at least six previous cycles—the STM rules require 
user experience with at least six previous cycles to allow for a reliable assessment 
of the current cycle. If there are not enough records in the recorded history of ERT, 
the evaluation for the first phase will not run, and the report with the alert to this 
situation is displayed.
The evaluation is possible until fulfilment at least one evaluation condition, e.g., 
for evaluation of the first phase, just enter the occurrence of cervical mucus, and 
the last dry day rule is activated. The accuracy of the evaluation depends on the 
amount of data collected, not only in the current cycle but also in previous cycles. 
The overall reliability of the ERT cannot be determined as the testing did not run 
with a statistically significant data set. As it is a precise didactic transposition of the 
rules and if accurate and clean data are entered, we assume reliability comparable to 
that of the symptothermal method. However, further testing with sufficient data is 
necessary to confirm this assumption.
6. Discussion
In this part of the paper, we discuss the problems associated with the use of NFP 
methods: the sense of using methods, determining reliability, and measuring basal 
body temperature.
The human body is an “unstable system,” and when we talk about fertility, 
women respond very sensitively to various stimuli. Every organism is unique; no 
two cycles of the tens of thousands of observed cycles are identical. Due to the cur-
rent rapid lifestyle, sedentary work, artificial lighting, or lack of physical exertion, 
menstrual cycle irregularities are more common than in the past, not to mention 
other reproductive health problems, e.g., polycystic ovary syndrome, myomas, 
pre-menstruation syndrome, etc. No device can predict in advance that there will be 
any irregularities in the current cycle that will shorten or extend the cycle. Nothing 
in the menstruation cycle can be predicted at a hundred percent. At the same 
time, there are periods in women’s lives—e.g., before the first menstruation, after 
delivery, or in climacterium—when hormonal conditions can properly disrupt the 
cycle. From the experience of lecturers teaching NFP methods, it can be argued that 
in these cases the devices or applications cannot reliably evaluate the course of the 
cycle and pairs have to rely on prolonged sexual abstinence or use of barrier contra-
ception due to inaccurate device estimation.
The accuracy of the outputs of the technical aids depends not only on the quality 
of the components they are made of but also on the software that makes the evalu-
ation itself. Even the finest instruments and the most sophisticated software for 
determining fertile and infertile days have their limits, and it is not good to rely 
blindly on them. Even those who welcome technical innovations are advised to 
supplement the information from the device with their personal assessment of fer-
tility symptoms (at least one symptom). Users will avoid unnecessary disappoint-
ment from possible failure, especially during nonstandard situations. Learning to 
understand some NFP methods is not as difficult as it may seem. Indeed, one of 
the prerequisites of NFP methods is knowing your own body, not mechanically 
thoughtless entering data into device/application.
The determination of the reliability of NFP methods can have a discussion for 
a long time. It is difficult to determine the evaluation criteria that will deliver the 
most relevant results. The most commonly used Pearl Index (PI) is under criti-
cism because of the fact that different PI values are found in the literature for one 
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must be subjected to in-depth testing on a sufficient number of cycles. Entered data 
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Applications and IT tools for NFP are an interesting research area, and based on 
how they were mentioned above, they have great potential. On the basis of these 
facts, we also decided to create a web site for evaluating the menstrual cycle accord-
ing to symptothermal method (STM). The IT tool SymRec is an accurate didactic 
transposition of rules of STM used in Slovakia with some restriction listed below. 
We followed the rules outlined in the book Handbook of Symptothermal Methods 
published by Couple to Couple League in Slovakia [27].
The goal of the work was to create an IT tool—electronic record table (ERT)—
similar to the printed record table used for symptothermal observation. ERT serves 
for daily data entry, storage data, and evaluating menstrual cycle according STM 
rules. Access to data is possible for every device connected to the Internet. ERT is 
available on the website: http://symrec.judak.eu/.
5.1 Didactic transposition of STM rules
Didactic transposition is the isolation of certain terms and properties from 
the environment in which they originated and their adaptation to the context in 
the new environment. In fact, it is the transfer of the regularities of the teaching 
or learning process (rules of some NFP method) from the analogue environment 
(manual paper method) to the digital environment (application, IT tool). It is an 
interpretation of NFP rules in the digital world using programming code. The origi-
nal manual STM has been transformed into an electronic version by transcription to 
PHP code. ERT evaluates the record according to these rules:
1. Evaluation of the first phase of preovulatory infertility:
• Last dry day rule
• Doctors experience rule
• Rule 20/21 days
• Döring rule
2. Evaluation of the third phase of postovulatory infertility:
• Rules R, B, and K—double-symptom rules (cervix mucus, basal body temperature)
• 4 T, 5 T, and Marshall rule—one-symptom rules (BBT)
• 5DMD—one-symptom rule (cervix mucus)
ERT expects that only valid temperatures are entered. Evaluation does not offer 
a possibility as “planning down” and averaging the temperatures, which are possible 
in manual evaluation in case of nonstandard temperature curves. To verify each 
rule, software checks at least six previous cycles and a maximum of thirteen cycles. 
According to the number of cycles in the recorded history of ERT, the evaluation is 
performed for the 8th recorded cycle, and a different evaluation rule is used for the 
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13th recorded cycle. It follows that for validation of all possibilities of evaluation, 
27 rules have to be created. For evaluation of the first phase preovulatory infertility, 
it is necessary to have recorded at least six previous cycles—the STM rules require 
user experience with at least six previous cycles to allow for a reliable assessment 
of the current cycle. If there are not enough records in the recorded history of ERT, 
the evaluation for the first phase will not run, and the report with the alert to this 
situation is displayed.
The evaluation is possible until fulfilment at least one evaluation condition, e.g., 
for evaluation of the first phase, just enter the occurrence of cervical mucus, and 
the last dry day rule is activated. The accuracy of the evaluation depends on the 
amount of data collected, not only in the current cycle but also in previous cycles. 
The overall reliability of the ERT cannot be determined as the testing did not run 
with a statistically significant data set. As it is a precise didactic transposition of the 
rules and if accurate and clean data are entered, we assume reliability comparable to 
that of the symptothermal method. However, further testing with sufficient data is 
necessary to confirm this assumption.
6. Discussion
In this part of the paper, we discuss the problems associated with the use of NFP 
methods: the sense of using methods, determining reliability, and measuring basal 
body temperature.
The human body is an “unstable system,” and when we talk about fertility, 
women respond very sensitively to various stimuli. Every organism is unique; no 
two cycles of the tens of thousands of observed cycles are identical. Due to the cur-
rent rapid lifestyle, sedentary work, artificial lighting, or lack of physical exertion, 
menstrual cycle irregularities are more common than in the past, not to mention 
other reproductive health problems, e.g., polycystic ovary syndrome, myomas, 
pre-menstruation syndrome, etc. No device can predict in advance that there will be 
any irregularities in the current cycle that will shorten or extend the cycle. Nothing 
in the menstruation cycle can be predicted at a hundred percent. At the same 
time, there are periods in women’s lives—e.g., before the first menstruation, after 
delivery, or in climacterium—when hormonal conditions can properly disrupt the 
cycle. From the experience of lecturers teaching NFP methods, it can be argued that 
in these cases the devices or applications cannot reliably evaluate the course of the 
cycle and pairs have to rely on prolonged sexual abstinence or use of barrier contra-
ception due to inaccurate device estimation.
The accuracy of the outputs of the technical aids depends not only on the quality 
of the components they are made of but also on the software that makes the evalu-
ation itself. Even the finest instruments and the most sophisticated software for 
determining fertile and infertile days have their limits, and it is not good to rely 
blindly on them. Even those who welcome technical innovations are advised to 
supplement the information from the device with their personal assessment of fer-
tility symptoms (at least one symptom). Users will avoid unnecessary disappoint-
ment from possible failure, especially during nonstandard situations. Learning to 
understand some NFP methods is not as difficult as it may seem. Indeed, one of 
the prerequisites of NFP methods is knowing your own body, not mechanically 
thoughtless entering data into device/application.
The determination of the reliability of NFP methods can have a discussion for 
a long time. It is difficult to determine the evaluation criteria that will deliver the 
most relevant results. The most commonly used Pearl Index (PI) is under criti-
cism because of the fact that different PI values are found in the literature for one 
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method [30]. Key parameters that are subject to comparability should be used to 
calculate the reliability of the method:
a. Frequency of sexual intercourse—the difference is in recording 1 unwanted 
pregnancy for 5 years at 1 intercourse as 1 pregnancy for 5 years at 300 (or 
more) intercourses.
b. Sample size—no sample size is specified for PI determination. The larger the 
sample, the more accurate the result.
c. Age of women—fertility is different at every woman’s age. The chance to 
conceive naturally in a 20-year-old woman is significantly higher than in a 
38-year-old woman. Also, men’s fertility rates decline by age [31].
d. The period of application of the method—unexpected pregnancies usually 
come in the first months of using a particular method. The longer the couples 
use the method, the more they are trained, and the number of unexpected 
pregnancies decreases.
e. User error—if an unexpected pregnancy occurs as a result of a conscious 
mistake by the user (e.g., situations where the partners have sexual intercourse 
during a period they know is fertile or use a barrier contraception during the 
fertile period), this situation should be recorded and should not be taken into 
account in establishing rate reliability.
f. BMI—overweight and obese women have a significant relationship between 
body mass index, spotting, menstrual cycle length, menstrual bleeding, and 
passing clots [30].
g. Diseases/medicaments/residual contraceptives.
A certain solution is to determine the reliability of typical use and perfect use, 
but the criteria mentioned above must be considered in this case too. Either, the 
individual approach of women to the use of a particular method should not be 
forgotten. Every woman is different; there is no universal solution for all women; 
however, solutions can be found for groups with similar method requirements. It is 
worth reminding that none of the NFP methods is 100% reliable (perfect use). In 
preventing unplanned pregnancy, only three methods of conceiving regulation have 
100% reliability:
• 100% sexual abstinence (no genital contact).
• Removal of both testes.
• Removal of both ovaries.
All other methods of conceiving control have some degrees of failure. Failures 
of NFP, e.g., symptothermal method, in the most cases are caused by inconsistent 
observation and recording of fertility symptoms, the use of barrier methods in the 
fertile phase of the cycle, and the conscious reliance on chance [27].
The basal temperature measurement time frame is a topic that we sup-
posedly should be giving due consideration too. Basal body temperature 
assessment is well described and applied. However, the time range of basal 
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temperature measuring remains a problem. This range is differently set 
for devices (Cyclotest myWay ±2 hours, Lady-Comp ±3 hours, Daysy no 
timeframe) and applications (Cyclotest mySense ±2 hours, Natural Cycles 
±2 hours). Of course, this problem is eliminated in continuous temperature 
monitoring (iFertracker, OvuSense), although a system for determining a 
particular temperature, e.g., from 100 measured values, can be discussed. The 
question remains how much are the objective results of the measured basal 
temperature in an interval of 6 hours. Under normal circumstances, BBT 
reaches its lowest in the early morning hours and then rises by about 0.05°C 
every half hour. Thus, the BBT measured outside the tolerated range of 30 min-
utes may not be accurate. Dr. Rötzer states in his work that basal temperatures 
measured outside the tolerance range (±30 minutes) after 7:30 am tend to have 
a greater effect on the temperature curve than deviations measured in the early 
morning hours [32]. So wide time frame is naturally comfortable for users, but 
the most accurate results can be achieved by measuring at the same time every 
day. The condition of daily measurement also plays an important role in the 
degree of reliability.
The task of experts is to find a solution in the field of NFP that confirms the 
words by Will Sacks, which aptly described the present state of fertility control with 
words: “I think the last century was about solving health problems with pills and 
synthetics, and this century is about solving health problems with software and 
data. The pill was an enormous boon for the previous generation. It set women free 
in so many ways, but it also came with side effects that a lot of women nowadays are 
finding unacceptable. Fertility Awareness is effective, low-cost, and side-effect-free 
so I think women and couples are finding it an attractive option. I also happen to 
think that Fertility Awareness is a consciousness-raising tool—it helps women tune 
into and feel powerful and in control of their health, and it helps male partners 
better understand the feminine. As consciousness and mindfulness increase glob-
ally, using synthetic hormones to control fertility is becoming less acceptable, and 
Fertility Awareness, which is the practice of living in harmony with your cycle, is 
becoming more obvious” [33].
7. Conclusion
The paper provides an overview of technical devices and applications used for 
evaluating the menstrual cycle and determining fertile and infertile days. In the 
first part, the principle of using and evaluating the four most commonly used NFP 
methods is briefly described. The next part is devoted to currently available infor-
mation technologies and electronic devices designed to evaluate the menstrual cycle 
in terms of NFP methods. The conditions of use, reliability, price, and limitations 
for the six devices and five applications are described. Finally, our proposed system 
of fertility assessment based on STM in the form of a website is described. The dis-
cussion critically evaluates the possibilities of use and weaknesses of the described 
technical devices and information means.
It follows that the success of the use of electronic devices or applications 
needs to be strengthened by some degree of knowledge and experience in 
assessing self-fertility. Although manufacturers report high reliability of their 
products, there is no need to blindly rely on the device and application results 
and evaluation should be complemented with own judgment. For a successful 
creation of quality and reliable application or device, cooperation from experts 
in various fields of science is needed, and research and experiences of practical 
users is necessary.
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use the method, the more they are trained, and the number of unexpected 
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during a period they know is fertile or use a barrier contraception during the 
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preventing unplanned pregnancy, only three methods of conceiving regulation have 
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• 100% sexual abstinence (no genital contact).
• Removal of both testes.
• Removal of both ovaries.
All other methods of conceiving control have some degrees of failure. Failures 
of NFP, e.g., symptothermal method, in the most cases are caused by inconsistent 
observation and recording of fertility symptoms, the use of barrier methods in the 
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for devices (Cyclotest myWay ±2 hours, Lady-Comp ±3 hours, Daysy no 
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±2 hours). Of course, this problem is eliminated in continuous temperature 
monitoring (iFertracker, OvuSense), although a system for determining a 
particular temperature, e.g., from 100 measured values, can be discussed. The 
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reaches its lowest in the early morning hours and then rises by about 0.05°C 
every half hour. Thus, the BBT measured outside the tolerated range of 30 min-
utes may not be accurate. Dr. Rötzer states in his work that basal temperatures 
measured outside the tolerance range (±30 minutes) after 7:30 am tend to have 
a greater effect on the temperature curve than deviations measured in the early 
morning hours [32]. So wide time frame is naturally comfortable for users, but 
the most accurate results can be achieved by measuring at the same time every 
day. The condition of daily measurement also plays an important role in the 
degree of reliability.
The task of experts is to find a solution in the field of NFP that confirms the 
words by Will Sacks, which aptly described the present state of fertility control with 
words: “I think the last century was about solving health problems with pills and 
synthetics, and this century is about solving health problems with software and 
data. The pill was an enormous boon for the previous generation. It set women free 
in so many ways, but it also came with side effects that a lot of women nowadays are 
finding unacceptable. Fertility Awareness is effective, low-cost, and side-effect-free 
so I think women and couples are finding it an attractive option. I also happen to 
think that Fertility Awareness is a consciousness-raising tool—it helps women tune 
into and feel powerful and in control of their health, and it helps male partners 
better understand the feminine. As consciousness and mindfulness increase glob-
ally, using synthetic hormones to control fertility is becoming less acceptable, and 
Fertility Awareness, which is the practice of living in harmony with your cycle, is 
becoming more obvious” [33].
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The paper provides an overview of technical devices and applications used for 
evaluating the menstrual cycle and determining fertile and infertile days. In the 
first part, the principle of using and evaluating the four most commonly used NFP 
methods is briefly described. The next part is devoted to currently available infor-
mation technologies and electronic devices designed to evaluate the menstrual cycle 
in terms of NFP methods. The conditions of use, reliability, price, and limitations 
for the six devices and five applications are described. Finally, our proposed system 
of fertility assessment based on STM in the form of a website is described. The dis-
cussion critically evaluates the possibilities of use and weaknesses of the described 
technical devices and information means.
It follows that the success of the use of electronic devices or applications 
needs to be strengthened by some degree of knowledge and experience in 
assessing self-fertility. Although manufacturers report high reliability of their 
products, there is no need to blindly rely on the device and application results 
and evaluation should be complemented with own judgment. For a successful 
creation of quality and reliable application or device, cooperation from experts 
in various fields of science is needed, and research and experiences of practical 
users is necessary.
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Reproductive Health and Family 
Planning Services in Africa: 
Looking beyond Individual and 
Household Factors
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Abstract
Worldwide, there have been remarkable gains in the provision and utilization 
of reproductive health and FP services. However, in Africa, despite increasing 
availability, utilization of these services is less than 50%, even though there are 
wide variations among and within the countries across the continent. Articles from 
peer-reviewed journals, technical reports, Internet articles, grey literature (official 
government documents, technical reports, etc.) and Demographic and Health 
Survey (DHS) reports were used as resource materials. Manual search of reference 
list of selected articles was done for further relevant materials. We also used for 
comparative analysis, the online StatCompiler tool (https://www.statcompiler.com/
en/) to extract data. Reproductive health and contraceptives have a lot of benefits to 
the individual, family and community. However, despite near universal knowledge 
and availability of reproductive health and FP services in Africa, utilization of these 
services is less than optimal. Several factors operating at individual, household 
and within the community influence utilization of services. These factors are the 
cause of poor maternal health and care that might hinder population health and the 
attainment of Sustainable Development Goals (SDGs). Interventions to promote 
and sustain utilization of services should target these factors at different levels 
depending upon relative role/s of these factors.
Keywords: antenatal care, facility delivery, skilled attendant, postnatal care, FP, 
service utilization, SSA
1. Introduction
Inequality in health care utilization and large disparities in health outcomes 
exists between countries and even within them. These differences largely are 
defined and perpetrated by a multitude of factors-social structures-and mediated 
by material and behavioral factors and by aspects of health system delivery [1]. 
Thirty years after the launch of Safe Motherhood Initiative, the health and well-
being of mothers and newborns have improved appreciably in many countries. 
However, countries with the highest burdens of mortality and illness have made 
least progress and inequalities between countries are increasing. Worldwide, each 
year, there are about 3.2 million stillborn babies, 4 million neonatal deaths and 
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by material and behavioral factors and by aspects of health system delivery [1]. 
Thirty years after the launch of Safe Motherhood Initiative, the health and well-
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0.5 million maternal deaths [2]. In majority of situations, the deaths are largely 
preventable [2, 3]. Around 99% of these deaths occurs in developing countries [2] 
out of which 11–17% of maternal deaths occurs during childbirth and 50–71% of it 
in the postpartum period [4]. While every pregnancy carries risks [4, 5] that must 
be addressed by skilled health providers, the timing, spacing and above all, the 
women’s ability to decide when to become pregnant are key to favorable pregnancy 
outcomes.
Sexual and reproductive health (SRH) is a relatively new concept in the context 
of the dynamics of contemporary public health issues. It is closely related to the trio 
of health, population and environment (PHE), the three topmost challenging issues 
that require global attention for solutions. SRH is significantly influenced by socio-
cultural, political and religious considerations [6, 7]. The five core components of 
sexual and reproductive health include among others improvement of antenatal, 
postnatal, postpartum and newborn care, provision of high-quality services includ-
ing family planning (FP), etc. Pregnancy is a physiological process of activities in 
a continuum, each activity (or stage) crucially influenced by the preceding activity 
(or stage).
It is well recognized that improving the women’s chances of surviving preg-
nancy and child birth relies on their access to reproductive health including FP. And 
within the continuum of maternity care, antenatal care (ANC) provides an avenue 
for important health care functions such as health education, health promotion, 
screening and diagnosis and disease prevention [8]. Studies have reported that 
ANC alone can reduce maternal mortality by up to 20%, given good quality and 
regular attendance [4, 9]. Maternal health care services in developing countries 
have evolved rather slowly. The first intervention to be implemented in a wide-
spread fashion within maternal health programs was antenatal care. Delivery care 
(either institutional or home-based) was a later addition [10], while systematic 
and regular postpartum follow-up and care are hardly available [11]. Poor maternal 
health thus remains a major reproductive health concern in most part of the devel-
oping nations including SSA. Relatively less progress has been made in the area of 
maternal health compared to the reductions in fertility and infant mortality [12]. It 
has been estimated that in 2009, the lifetime risk of maternal death in SSA was 1 in 
16 (compared to 1 in 2800 in developed regions) and that maternal mortality ratios 
were 540 in Ghana, 1000 in Kenya, 800 in Nigeria and 880 in Uganda, respectively 
[13, 14]. The sad reality of the situation is that these deaths can be prevented by 
simple and cost-effective public health interventions such as giving pregnant 
women tetanus toxoid injections together with other antenatal care services as well 
as postnatal care. Because women comprise more than half of the total population 
of most SSA countries, poor maternal health and care can be a huge obstacle to 
human and sustainable socio-economic development.
Access to reproductive health services is skewed in favor of urban areas to the 
detriment of the majority of rural population. Studies have shown how socio-
economic, socio-cultural variables and demographics influenced the demand for 
and utilization of maternal and child health services [15–17]. For instance, maternal 
education has been found to be a significant predictor of the use of maternal health 
care services [18, 19]. Additionally, the costs [20], location [21, 22] and quality of 
health services are also important. Predictably, these factors interact in different 
ways to determine the use of health care. Thus, many women in SSA have unmet 
need for contraceptive and reproductive health services. Unmet reproductive health 
needs exist if there is a gap between a perceived need and the current available 
options to satisfy the need [23].
Family planning (FP) for the purpose of child spacing is not alien to African 
culture. Traditionally, African mothers practice intensive breastfeeding lasting 
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longer than 24 months (and in some cultures up to 36 months). Some African 
societies practice postpartum marital sexual separation where the woman spends 
most of the postpartum period with her parents receiving special traditional and 
cultural rites for health and vitality [24]. This long period of voluntary separation 
ensures that sexual intercourse does not happen to avoid pregnancy. However, 
modern family planning programs, that is, organized effort to provide contra-
ception to women and men, appeared on the sub-continent in 1950s. During 
the 1950s, there were attempts to establish family planning programs across the 
region. First, it was in Rhodesia in 1955, then Uganda in 1956, then Kenya in 1957, 
Mauritius in 1957, Nigeria in 1958 and Sierra Leone in 1959 [25]. By mid-1960s, 
family planning clinics were scattered across some of these countries offering 
family planning commodities. Thus, family planning clinics sprang up in the 
major cities such as Salisbury (Zimbabwe), Nairobi (Kenya), Kampala (Uganda), 
Lagos and Ibadan (Nigeria), Freetown (Liberia) and Accra (Ghana). Though these 
family planning clinics were established either by the government or by private 
associations, there was vehement resistance coming from both the religious and 
cultural institutions. The landscape remained the same well into 1970s with many 
countries in this region showing lackadaisical attitudes toward expansion of the 
services, with quite a handful of these governments indicating that they are not 
worried about the rate of population growth. However, this position began to 
change by early 1980s with a global economic meltdown and these governments 
actively saw the need to intervene to bring down fertility rate via vigorous family 
planning programs. Since a woman’s overall reproductive health is determined 
collectively by the overall coverage, context, quality and utilization, it is important 
to assess the levels, trends and barriers of service utilization. Understanding the 
determinants that affect the utilization of these important reproductive health and 
FP services can assist in developing policies and designing interventions aimed at 
improving service utilization in countries across SSA. This will go a long way in 
reducing maternal mortality.
2. Reproductive health: antenatal care
Antenatal care (ANC) basically means care before birth. The aim of ANC is to 
assist pregnant women to remain healthy, finding and correcting adverse conditions 
when present and aiding the health of the unborn baby [26]. Within the continuum 
of maternity care, ANC provides a platform for critical health care functions. These 
include health promotion, screening and diagnosis and disease prevention [8]. 
Studies have reported that ANC alone can reduce maternal mortality by 20% with 
regular attendance and of good quality [4, 9]. Research has shown that achieving 
the World Health Organization (WHO) recommended four individualized ANC 
visits at 90% coverage rate could save about 37–71% [27] of newborn deaths, and 
67% of death of newborns in SSA could be prevented by high average of care [28]. 
It also provides an avenue for encouraging skilled attendance at birth [29], early 
detection and management of potential complications [30] and provision of health 
education on good nutrition, family planning and breastfeeding [31, 32]. ANC 
during pregnancy has a positive influence on the utilization of postnatal health care 
services. The developed world has achieved remarkable success in ANC coverage 
with over 80% of woman having at least one ANC visit. However, many countries 
in SSA still have less impressive levels below the WHO recommended four or more 
visits. In most situations, the women in SSA wait till second or third trimester to 
make the initial ANC visit, thereby reducing the chances of making at least four 
visits [32, 33].
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Several studies have assessed individual and household determinants in the 
utilization of reproductive health services in SSA. For instance, socio-demographic, 
religion, accessibility, educational status and affordability (socio-economic status) 
[12, 34–38] were all found to determine antenatal care utilization. The influence 
of these factors varied between countries across the continent. In Zimbabwe, poor 
quality of care and attitudes of service providers were barriers to utilization of 
services [39]. It can be assumed that utilization of maternal health services depends 
not only on individual and household factors but also importantly within the 
context of the country where the individual resides. Understanding this context is 
the key to improving service utilization since the individuals or couples are nested 
with families, which are in turn nested within communities. Studies have shown 
that family and community membership constitutes a major determinant in access 
to ANC services [27, 40].
3. Health facility delivery and skilled attendant at birth
While motherhood is often a positive and fulfilling experience, for too many 
women, it is associated with suffering, pain, ill-health and even death. Delivery at 
a health facility with assistance of skilled medical professional reduces the risk of 
complications and infections during labor and delivery. Skilled birth attendance is 
the process by which a woman is provided adequate care by trained health person-
nel during labor, delivery and early postnatal period. It is the single most cost-effec-
tive intervention in reducing maternal and perinatal mortality. In the developing 
countries, one third of all pregnant women receive no health talk, 60% of all deliv-
eries take place outside health care facilities and about 46.7% of all deliveries are 
attended to by trained health personnel [41, 42]. Epidemiologic data on maternal 
deaths in developing countries revealed that two-thirds of death occur around the 
time of delivery [43]. Obstetric complication can occur around the time of delivery 
and cannot be predicted. Thus, it is important that all pregnant women have access 
to a skilled attendant to manage normal delivery and who can also recognize and 
manage obstetric complications or refer to high-level facility when necessary.
Across the continent, variations exist at individual, household and community 
contexts on the factors that influence the utilization of these services. Several 
individual factors that affect the use of ANC significantly influence the use of 
skilled personnel for delivery. Skilled attendance at delivery is an important fac-
tor in preventing maternal deaths and it is also crucial to prevent stillbirths and 
improve newborn survival [44, 45]. There are wide variations across SSA on health 
facility delivery and birth attended to by skilled personnel. In Nigeria, health 
facility delivery (39%) and skilled attendant at delivery (43%) are very low [46]. 
While in Zimbabwe, 77% of births took place in health facility and about 8 in 10 
deliveries are assisted by a skilled provider (majority by a nurse or nurse midwife, 
66%) [47]. There has been a progressive remarkable improvement in Ghana, where 
facility delivery increased from 54% in 2007 to 79% in 2017 and skilled attendant 
at delivery was 79% [48]. According to recent demographic and health survey 
(DHS), facility delivery and skilled attendant in Tanzania were respectively 63% 
and 64% [49]. Previous studies have shown consistent association between urban 
residence and utilization of ANC, delivery and PNC services [50]. In general, the 
decisions that lead women to use services seem to reside within the context of their 
marriage. Since individuals and families all live within the community, it definitely 
can influence personal health–seeking behavior as there are personnel beliefs and 
attitudes and community norms [51]. Again, religion and to a large extent ethnicity 
often influence beliefs, norms and values in relation to pregnancy, childbirth and 
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utilization of services [44, 50]. The variations in factors and diversity within the 
populations of women could be explained by differences in women’s autonomy, 
empowerment, gender relationships and social networks, which are in turn influ-
enced by embedded social structures, religion and cultural beliefs. For instance, 
non-white South African women usually attend ANC later in pregnancy because it 
is viewed as being necessary to allow access to facility delivery [52].
Even though ANC is universally free in most countries in SSA, this does not 
translate into use of skilled attendance at delivery, since less than 50% of all women 
are assisted by skilled professional during delivery. SSA is the region with the lowest 
coverage of skilled delivery utilization with only 45% of women having skilled 
attendants at birth [50]. From a country-specific context, there are wide variations 
across and within the countries across the continent, with 10% skilled delivery 
utilization in Ethiopia [53], 43% in Nigeria [46] to 52% in Kenya [54].
About half of postpartum deaths take place within one day of delivery and 
roughly 70% occur within the first week. Obviously, there is mismatch between 
women’s need for reproductive health care and what is currently available in terms 
of its provision and service utilization across SSA. Large body of evidence on factors 
contributing to poor service utilization consistently showed physical and financial 
barriers as well as educational level, parity, residence, ANC attendance and social 
status of the women [50, 55–58]. Expectedly, better educated women and those 
who had better autonomy in decisions pertaining to household expenses were more 
likely to have facility delivery [55]. In the context of achieving universal health 
coverage through improving health systems strengthening, barriers still remain in 
the utilization of reproductive health services.
4. Postnatal care (PNC)
Worldwide, about half of maternal deaths occur within the first 24 h after deliv-
ery. WHO guidelines that most countries in SSA adopted recommends that women 
who deliver in a health facility receive postnatal care check in the 24 h after delivery, 
while those who gave birth outside a health facility should be referred for postnatal 
checks in health facility within 12 h after delivery. PNC is part of continuum of care 
started from ANC. Thus, antenatal care promotes the use of PNC services for the 
mother-child pair [33]. As a major component of PNC, immunization remains to 
be one of the most effective public health interventions that have been proven to 
prevent about 24% of the 10 million deaths of children under five years annually 
[59]. Postnatal care (PNC) is one of the recommended strategies to reduce maternal 
and newborn deaths during the postpartum period [27, 60]. It is further recom-
mended that mothers and newborns receive PNC in health facilities for at least 24 
h after birth for those who delivered in the facility. While for those who delivered 
outside the health facility (at home), the first postnatal contact should be within 24 
h of birth. At least 3 additional postnatal contacts are recommended for both moth-
ers and newborns on day 3 (48–72 h), between days 7 and 14 after birth and 6 weeks 
after birth [61]. As with other maternal health services, PNC utilization is weak or 
low in SSA among all reproductive and child health programs. PNC utilization in 
Ethiopia is very low with only 7.1% of women [50] having PNC service in the first 2 
days after delivery, 42% in Nigeria [46], 57% in Zimbabwe [47], 12.8% in Rwanda 
[62], 31% in Tanzania [63] and 58% in Uganda [64], respectively.
Again, physical accessibility is one of the most important variables in health 
service utilization. Several studies have shown that proximity of health care services 
play an important role in service utilization [21, 50, 65]. A number of individual, 
household and institutional characteristics affect women’s decision in seeking 
Family Planning and Reproductive Health
44
Several studies have assessed individual and household determinants in the 
utilization of reproductive health services in SSA. For instance, socio-demographic, 
religion, accessibility, educational status and affordability (socio-economic status) 
[12, 34–38] were all found to determine antenatal care utilization. The influence 
of these factors varied between countries across the continent. In Zimbabwe, poor 
quality of care and attitudes of service providers were barriers to utilization of 
services [39]. It can be assumed that utilization of maternal health services depends 
not only on individual and household factors but also importantly within the 
context of the country where the individual resides. Understanding this context is 
the key to improving service utilization since the individuals or couples are nested 
with families, which are in turn nested within communities. Studies have shown 
that family and community membership constitutes a major determinant in access 
to ANC services [27, 40].
3. Health facility delivery and skilled attendant at birth
While motherhood is often a positive and fulfilling experience, for too many 
women, it is associated with suffering, pain, ill-health and even death. Delivery at 
a health facility with assistance of skilled medical professional reduces the risk of 
complications and infections during labor and delivery. Skilled birth attendance is 
the process by which a woman is provided adequate care by trained health person-
nel during labor, delivery and early postnatal period. It is the single most cost-effec-
tive intervention in reducing maternal and perinatal mortality. In the developing 
countries, one third of all pregnant women receive no health talk, 60% of all deliv-
eries take place outside health care facilities and about 46.7% of all deliveries are 
attended to by trained health personnel [41, 42]. Epidemiologic data on maternal 
deaths in developing countries revealed that two-thirds of death occur around the 
time of delivery [43]. Obstetric complication can occur around the time of delivery 
and cannot be predicted. Thus, it is important that all pregnant women have access 
to a skilled attendant to manage normal delivery and who can also recognize and 
manage obstetric complications or refer to high-level facility when necessary.
Across the continent, variations exist at individual, household and community 
contexts on the factors that influence the utilization of these services. Several 
individual factors that affect the use of ANC significantly influence the use of 
skilled personnel for delivery. Skilled attendance at delivery is an important fac-
tor in preventing maternal deaths and it is also crucial to prevent stillbirths and 
improve newborn survival [44, 45]. There are wide variations across SSA on health 
facility delivery and birth attended to by skilled personnel. In Nigeria, health 
facility delivery (39%) and skilled attendant at delivery (43%) are very low [46]. 
While in Zimbabwe, 77% of births took place in health facility and about 8 in 10 
deliveries are assisted by a skilled provider (majority by a nurse or nurse midwife, 
66%) [47]. There has been a progressive remarkable improvement in Ghana, where 
facility delivery increased from 54% in 2007 to 79% in 2017 and skilled attendant 
at delivery was 79% [48]. According to recent demographic and health survey 
(DHS), facility delivery and skilled attendant in Tanzania were respectively 63% 
and 64% [49]. Previous studies have shown consistent association between urban 
residence and utilization of ANC, delivery and PNC services [50]. In general, the 
decisions that lead women to use services seem to reside within the context of their 
marriage. Since individuals and families all live within the community, it definitely 
can influence personal health–seeking behavior as there are personnel beliefs and 
attitudes and community norms [51]. Again, religion and to a large extent ethnicity 
often influence beliefs, norms and values in relation to pregnancy, childbirth and 
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utilization of services [44, 50]. The variations in factors and diversity within the 
populations of women could be explained by differences in women’s autonomy, 
empowerment, gender relationships and social networks, which are in turn influ-
enced by embedded social structures, religion and cultural beliefs. For instance, 
non-white South African women usually attend ANC later in pregnancy because it 
is viewed as being necessary to allow access to facility delivery [52].
Even though ANC is universally free in most countries in SSA, this does not 
translate into use of skilled attendance at delivery, since less than 50% of all women 
are assisted by skilled professional during delivery. SSA is the region with the lowest 
coverage of skilled delivery utilization with only 45% of women having skilled 
attendants at birth [50]. From a country-specific context, there are wide variations 
across and within the countries across the continent, with 10% skilled delivery 
utilization in Ethiopia [53], 43% in Nigeria [46] to 52% in Kenya [54].
About half of postpartum deaths take place within one day of delivery and 
roughly 70% occur within the first week. Obviously, there is mismatch between 
women’s need for reproductive health care and what is currently available in terms 
of its provision and service utilization across SSA. Large body of evidence on factors 
contributing to poor service utilization consistently showed physical and financial 
barriers as well as educational level, parity, residence, ANC attendance and social 
status of the women [50, 55–58]. Expectedly, better educated women and those 
who had better autonomy in decisions pertaining to household expenses were more 
likely to have facility delivery [55]. In the context of achieving universal health 
coverage through improving health systems strengthening, barriers still remain in 
the utilization of reproductive health services.
4. Postnatal care (PNC)
Worldwide, about half of maternal deaths occur within the first 24 h after deliv-
ery. WHO guidelines that most countries in SSA adopted recommends that women 
who deliver in a health facility receive postnatal care check in the 24 h after delivery, 
while those who gave birth outside a health facility should be referred for postnatal 
checks in health facility within 12 h after delivery. PNC is part of continuum of care 
started from ANC. Thus, antenatal care promotes the use of PNC services for the 
mother-child pair [33]. As a major component of PNC, immunization remains to 
be one of the most effective public health interventions that have been proven to 
prevent about 24% of the 10 million deaths of children under five years annually 
[59]. Postnatal care (PNC) is one of the recommended strategies to reduce maternal 
and newborn deaths during the postpartum period [27, 60]. It is further recom-
mended that mothers and newborns receive PNC in health facilities for at least 24 
h after birth for those who delivered in the facility. While for those who delivered 
outside the health facility (at home), the first postnatal contact should be within 24 
h of birth. At least 3 additional postnatal contacts are recommended for both moth-
ers and newborns on day 3 (48–72 h), between days 7 and 14 after birth and 6 weeks 
after birth [61]. As with other maternal health services, PNC utilization is weak or 
low in SSA among all reproductive and child health programs. PNC utilization in 
Ethiopia is very low with only 7.1% of women [50] having PNC service in the first 2 
days after delivery, 42% in Nigeria [46], 57% in Zimbabwe [47], 12.8% in Rwanda 
[62], 31% in Tanzania [63] and 58% in Uganda [64], respectively.
Again, physical accessibility is one of the most important variables in health 
service utilization. Several studies have shown that proximity of health care services 
play an important role in service utilization [21, 50, 65]. A number of individual, 
household and institutional characteristics affect women’s decision in seeking 
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health care. In general, despite the availability of reproductive health services, the 
decisions that lead women to use the services resides within the context of their 
marriage, household and family/community settings. The use of ANC during preg-
nancy is a major predictor of subsequent use of skilled delivery and PNC services. 
Therefore, the importance of ANC utilization as a key entry point to increase PNC 
services cannot be overemphasized. The early postpartum period can be targeted as 
the best period to discuss FP methods with the couples.
5. Family planning: levels of knowledge of contraceptive methods
Knowledge of at least any modern method among the women is almost universal 
across the countries (Table 1). The earliest information on knowledge of any mod-
ern method of contraception is the Nigeria Demographic and Health Survey (DHS) 
of 1990 and it reported a level of 41.2%, which coincidentally is lowest among the 
countries, while Burundi reported the highest level of 99.2% in 2016–2017 [66]. The 
level of knowledge varied markedly among countries with lowest knowledge level 
of 63.5% reported from Chad DHS of 2014–2015 to the highest (universal) of 100% 
in Rwanda [66]. In terms of percent change, Comoros recorded the smallest change 
in knowledge of 0.4%, while Nigeria recorded the highest of 52.7%.
5.1 Levels and trends of ever use of modern contraception
The level and trend in ever use of modern contraception among the women 
was reported by 24 countries; many other countries did not collect this informa-
tion between surveys. Ever use of modern contraception was lowest in Chad, 2.8% 
(1996/1997 survey) and 5.2% in most recent survey (2004) while Zimbabwe had 
the highest levels of 85.2% (2005/2006 survey) [47], respectively. Malawi recorded 
the greatest change (increase) in ever use of modern contraception of 55.4%. There 
has always being a great gap between knowledge and practice (ever use) of modern 
contraception particularly in sub-Saharan Africa (Figure 1) [67]. The difference 
between knowledge and ever use of a modern method of contraception is widest in 
Niger (77.6%) and narrowest in Zimbabwe (14.5%). This is not surprising as Niger 
Republic is traditionally a high-fertility country coupled with low literacy level, 
strong cultural and religious opposition to modern contraception and early age at 
marriage. However, the story is different with Zimbabwe often cited as one of the 
few success stories in sub-Saharan Africa where family planning services appeared 
in the country as far back as 1953 coupled with cultural and religious tolerance to its 
use [68].
5.2 Levels and trends of current use of modern contraception
Current use of modern contraception among countries in SSA showed variabil-
ity with Chad having the lowest of 5.0%, while Zimbabwe had the highest at 65.8%. 
Two countries, Liberia and Senegal, had their earliest DHS to have been conducted 
in 1986, which showed a very low uptake of modern contraception at 5.5% and 
2.1%, respectively. South Africa conducted its earliest DHS in 1998 with an uptake 
of modern contraception of 55.1%; the same country that conducted its recent DHS 
in 2016 reported a decline in uptake to 54.0% (or a drop of 1.1%). Malawi recorded 
the greatest change between its earliest and most recent survey of 50.7% [66]. 
Again, the greatest disparity between knowledge and current use of modern con-
traception is as shown in Figure 2. Across the globe, this pattern has been reported 
particularly in developing countries [68].
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5.3 Sources of modern contraceptive methods
It is generally believed that as the demand for modern contraception increases, 
the supply as well as outlets will increase and at the same time become diversified 
[67]. Initially, modern contraception is almost solely provided by government 
through its formal outlets such as hospitals, family planning clinics, health clinics, 
Country Earliest Recent Change
1 Benin 76.2 96.3 20.1
2 Burkina Faso 63.3 97.5 34.2
3 Burundi 99.2 99.7 0.5
4 Cameroon 62.9 94.0 31.1
5 Chad 42.8 63.5 20.7
6 Comoros 98.1 98.5 0.4
7 Congo 96.3 98.6 2.3
8 Congo Democratic Republic 76.7 89.9 13.2
9 Cote d’Ivoire 71.5 93.2 21.7
10 Eritrea 62.0 87.2 25.2
11 Ethiopia 85.3 98.7 13.4
12 Gabon 94.7 97.6 2.9
13 Ghana 90.7 99.2 8.5
14 Guinea 69.1 84.8 15.7
15 Kenya 96.9 98.7 1.8
16 Lesotho 98.1 99.5 1.4
17 Liberia 86.7 98.6 11.9
18 Madagascar 61.7 95.0 33.3
19 Malawi 91.8 99.6 7.8
20 Mali 64.6 94.4 29.8
21 Mozambique 60.4 96.3 35.9
22 Namibia 90.3 99.8 9.5
23 Niger 58.0 89.3 31.3
24 Nigeria 41.2 93.9 52.7
25 Rwanda 96.8 100.0 3.2
26 Senegal 70.4 97.2 26.8
27 Sierra Leone 66.2 93.7 27.5
28 South Africa 98.0 99.9 1.9
29 Tanzania 77.6 99.1 21.5
30 Togo 93.4 97.1 3.7
31 Uganda 91.6 99.7 8.1
32 Zambia 90.7 99.7 9.0
33 Zimbabwe 98.5 99.7 1.2
Table 1. 
Percentage of currently married women who know any modern method of contraception, DHS surveys 
1990–2018 [66].
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health care. In general, despite the availability of reproductive health services, the 
decisions that lead women to use the services resides within the context of their 
marriage, household and family/community settings. The use of ANC during preg-
nancy is a major predictor of subsequent use of skilled delivery and PNC services. 
Therefore, the importance of ANC utilization as a key entry point to increase PNC 
services cannot be overemphasized. The early postpartum period can be targeted as 
the best period to discuss FP methods with the couples.
5. Family planning: levels of knowledge of contraceptive methods
Knowledge of at least any modern method among the women is almost universal 
across the countries (Table 1). The earliest information on knowledge of any mod-
ern method of contraception is the Nigeria Demographic and Health Survey (DHS) 
of 1990 and it reported a level of 41.2%, which coincidentally is lowest among the 
countries, while Burundi reported the highest level of 99.2% in 2016–2017 [66]. The 
level of knowledge varied markedly among countries with lowest knowledge level 
of 63.5% reported from Chad DHS of 2014–2015 to the highest (universal) of 100% 
in Rwanda [66]. In terms of percent change, Comoros recorded the smallest change 
in knowledge of 0.4%, while Nigeria recorded the highest of 52.7%.
5.1 Levels and trends of ever use of modern contraception
The level and trend in ever use of modern contraception among the women 
was reported by 24 countries; many other countries did not collect this informa-
tion between surveys. Ever use of modern contraception was lowest in Chad, 2.8% 
(1996/1997 survey) and 5.2% in most recent survey (2004) while Zimbabwe had 
the highest levels of 85.2% (2005/2006 survey) [47], respectively. Malawi recorded 
the greatest change (increase) in ever use of modern contraception of 55.4%. There 
has always being a great gap between knowledge and practice (ever use) of modern 
contraception particularly in sub-Saharan Africa (Figure 1) [67]. The difference 
between knowledge and ever use of a modern method of contraception is widest in 
Niger (77.6%) and narrowest in Zimbabwe (14.5%). This is not surprising as Niger 
Republic is traditionally a high-fertility country coupled with low literacy level, 
strong cultural and religious opposition to modern contraception and early age at 
marriage. However, the story is different with Zimbabwe often cited as one of the 
few success stories in sub-Saharan Africa where family planning services appeared 
in the country as far back as 1953 coupled with cultural and religious tolerance to its 
use [68].
5.2 Levels and trends of current use of modern contraception
Current use of modern contraception among countries in SSA showed variabil-
ity with Chad having the lowest of 5.0%, while Zimbabwe had the highest at 65.8%. 
Two countries, Liberia and Senegal, had their earliest DHS to have been conducted 
in 1986, which showed a very low uptake of modern contraception at 5.5% and 
2.1%, respectively. South Africa conducted its earliest DHS in 1998 with an uptake 
of modern contraception of 55.1%; the same country that conducted its recent DHS 
in 2016 reported a decline in uptake to 54.0% (or a drop of 1.1%). Malawi recorded 
the greatest change between its earliest and most recent survey of 50.7% [66]. 
Again, the greatest disparity between knowledge and current use of modern con-
traception is as shown in Figure 2. Across the globe, this pattern has been reported 
particularly in developing countries [68].
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5.3 Sources of modern contraceptive methods
It is generally believed that as the demand for modern contraception increases, 
the supply as well as outlets will increase and at the same time become diversified 
[67]. Initially, modern contraception is almost solely provided by government 
through its formal outlets such as hospitals, family planning clinics, health clinics, 
Country Earliest Recent Change
1 Benin 76.2 96.3 20.1
2 Burkina Faso 63.3 97.5 34.2
3 Burundi 99.2 99.7 0.5
4 Cameroon 62.9 94.0 31.1
5 Chad 42.8 63.5 20.7
6 Comoros 98.1 98.5 0.4
7 Congo 96.3 98.6 2.3
8 Congo Democratic Republic 76.7 89.9 13.2
9 Cote d’Ivoire 71.5 93.2 21.7
10 Eritrea 62.0 87.2 25.2
11 Ethiopia 85.3 98.7 13.4
12 Gabon 94.7 97.6 2.9
13 Ghana 90.7 99.2 8.5
14 Guinea 69.1 84.8 15.7
15 Kenya 96.9 98.7 1.8
16 Lesotho 98.1 99.5 1.4
17 Liberia 86.7 98.6 11.9
18 Madagascar 61.7 95.0 33.3
19 Malawi 91.8 99.6 7.8
20 Mali 64.6 94.4 29.8
21 Mozambique 60.4 96.3 35.9
22 Namibia 90.3 99.8 9.5
23 Niger 58.0 89.3 31.3
24 Nigeria 41.2 93.9 52.7
25 Rwanda 96.8 100.0 3.2
26 Senegal 70.4 97.2 26.8
27 Sierra Leone 66.2 93.7 27.5
28 South Africa 98.0 99.9 1.9
29 Tanzania 77.6 99.1 21.5
30 Togo 93.4 97.1 3.7
31 Uganda 91.6 99.7 8.1
32 Zambia 90.7 99.7 9.0
33 Zimbabwe 98.5 99.7 1.2
Table 1. 
Percentage of currently married women who know any modern method of contraception, DHS surveys 
1990–2018 [66].
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etc. However, with an increase in demand and acceptance, the sources began to 
expand and more providers appeared in the market such as private non-govern-
mental organizations and religious and faith-based organizations (Table 2). Across 
sub-Saharan Africa, public outlet is the predominant as well as important source 
of information on contraception. This is not surprising because of the misconcep-
tions associated with it. It is much later that private medical outlets and then other 
private non-medical outlets joined the supply and service outlet.
Marked variability exists across the continent on public source as supplier 
of contraceptive commodity accounting for 20.7% in Democratic Republic of 
Congo, 91.3% Rwanda and 93.3% Niger, respectively [66]. Regarding the changes 
in the proportion of public source of information and contraception, Uganda and 
Madagascar recorded the greatest changes. There was a decline in Uganda, while 
Madagascar recorded an increase in the role of public outlet of contraception. The 
reasons for this might be due to influx of other non-public (or governmental) sup-
plies or a decline in quality of services as well as supply of the commodity. For those 
that recorded an increase in this proportion, probably the government in recent 
times is becoming more active in FP programs. Decline in the proportion of women 
obtaining information and contraception from public outlet has been documented 
earlier [67]. In this analysis, 12 countries (or 38%) experienced a decline in the 
percentage of women getting contraception from public channels, while in the 
remaining countries, it increased. Thus, it is reasonable to assume that an expansion 
of high-quality services might increase women’s motivation to use these services.
5.4 Contraceptive discontinuation and switching
There are several reasons why a woman currently using a modern contraception 
would discontinue or switch to another method. Some of these reasons could be 
health-related such as experiencing intolerable side effects (hypertension, obesity, 
etc.). More often, it is fertility-related such as a desire to become pregnant, or it 
Figure 1. 
Gap between knowledge and ever use of modern contraception, DHS surveys [66].
Figure 2. 
Gap between knowledge and current use of modern contraception, DHS surveys [66].
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could be due to marital problems such as disapproval by the spouse or economic 
such as cost or health system factors such as lack of accessibility or availability to 
continue with the current method. Studies have shown that fear of side effects 
especially those associated with hormonal contraception has been reported to act 
as strong barriers [69–72], while other studies revealed fear of infertility, menstrual 
irregularities, cancer, weight gain [73–76] and spousal communication [77–79] as 
barriers to use contraceptives.
Country Earliest Recent Change
1 Benin 43.5 62.4 18.9
2 Burkina Faso 64.6 73.7 9.1
3 Burundi 87.3 80.9 -6.4
4 Cameroon 30.5 20.0 -10.5
5 Chad 59.3 71.6 12.3
6 Comoros 77.6 87.2 9.6
7 Congo 22.0 19.4 -2.6
8 Congo Democratic Republic 20.7 31.1 10.4
9 Cote d'Ivoire 25.5 26.3 0.8
10 Eritrea 78.4 74.0 -4.4
11 Ethiopia 77.5 83.8 6.3
12 Ghana 35.7 63.7 28.0
13 Guinea 49.9 63.6 13.7
14 Kenya 70.5 59.9 -10.6
15 Lesotho 56.7 62.0 5.3
16 Liberia 50.8 72.3 21.5
17 Madagascar 38.8 72.8 34.0
18 Malawi 69.9 79.4 9.5
19 Mali 52.0 77.2 25.2
20 Mozambique 82.7 76.6 -6.1
21 Namibia 86.4 73.7 -12.7
22 Niger 93.3 85.3 -8.0
23 Nigeria 37.1 54.3 17.2
24 Rwanda 69.0 91.3 22.3
25 Senegal 59.1 86.5 27.4
26 Sierra Leone 50.4 68.4 18.0
27 South Africa 83.6 80.4 -3.2
28 Tanzania 72.9 60.8 -12.1
29 Togo 41.7 52.9 11.2
30 Uganda 82.7 58.5 -24.2
31 Zambia 56.1 81.6 25.5
32 Zimbabwe 88.9 73.0 -15.9
Table 2. 
Percentage of women currently using modern contraceptive methods who received their most recent supply or 
information from a public source, DHS surveys [66].
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etc. However, with an increase in demand and acceptance, the sources began to 
expand and more providers appeared in the market such as private non-govern-
mental organizations and religious and faith-based organizations (Table 2). Across 
sub-Saharan Africa, public outlet is the predominant as well as important source 
of information on contraception. This is not surprising because of the misconcep-
tions associated with it. It is much later that private medical outlets and then other 
private non-medical outlets joined the supply and service outlet.
Marked variability exists across the continent on public source as supplier 
of contraceptive commodity accounting for 20.7% in Democratic Republic of 
Congo, 91.3% Rwanda and 93.3% Niger, respectively [66]. Regarding the changes 
in the proportion of public source of information and contraception, Uganda and 
Madagascar recorded the greatest changes. There was a decline in Uganda, while 
Madagascar recorded an increase in the role of public outlet of contraception. The 
reasons for this might be due to influx of other non-public (or governmental) sup-
plies or a decline in quality of services as well as supply of the commodity. For those 
that recorded an increase in this proportion, probably the government in recent 
times is becoming more active in FP programs. Decline in the proportion of women 
obtaining information and contraception from public outlet has been documented 
earlier [67]. In this analysis, 12 countries (or 38%) experienced a decline in the 
percentage of women getting contraception from public channels, while in the 
remaining countries, it increased. Thus, it is reasonable to assume that an expansion 
of high-quality services might increase women’s motivation to use these services.
5.4 Contraceptive discontinuation and switching
There are several reasons why a woman currently using a modern contraception 
would discontinue or switch to another method. Some of these reasons could be 
health-related such as experiencing intolerable side effects (hypertension, obesity, 
etc.). More often, it is fertility-related such as a desire to become pregnant, or it 
Figure 1. 
Gap between knowledge and ever use of modern contraception, DHS surveys [66].
Figure 2. 
Gap between knowledge and current use of modern contraception, DHS surveys [66].
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could be due to marital problems such as disapproval by the spouse or economic 
such as cost or health system factors such as lack of accessibility or availability to 
continue with the current method. Studies have shown that fear of side effects 
especially those associated with hormonal contraception has been reported to act 
as strong barriers [69–72], while other studies revealed fear of infertility, menstrual 
irregularities, cancer, weight gain [73–76] and spousal communication [77–79] as 
barriers to use contraceptives.
Country Earliest Recent Change
1 Benin 43.5 62.4 18.9
2 Burkina Faso 64.6 73.7 9.1
3 Burundi 87.3 80.9 -6.4
4 Cameroon 30.5 20.0 -10.5
5 Chad 59.3 71.6 12.3
6 Comoros 77.6 87.2 9.6
7 Congo 22.0 19.4 -2.6
8 Congo Democratic Republic 20.7 31.1 10.4
9 Cote d'Ivoire 25.5 26.3 0.8
10 Eritrea 78.4 74.0 -4.4
11 Ethiopia 77.5 83.8 6.3
12 Ghana 35.7 63.7 28.0
13 Guinea 49.9 63.6 13.7
14 Kenya 70.5 59.9 -10.6
15 Lesotho 56.7 62.0 5.3
16 Liberia 50.8 72.3 21.5
17 Madagascar 38.8 72.8 34.0
18 Malawi 69.9 79.4 9.5
19 Mali 52.0 77.2 25.2
20 Mozambique 82.7 76.6 -6.1
21 Namibia 86.4 73.7 -12.7
22 Niger 93.3 85.3 -8.0
23 Nigeria 37.1 54.3 17.2
24 Rwanda 69.0 91.3 22.3
25 Senegal 59.1 86.5 27.4
26 Sierra Leone 50.4 68.4 18.0
27 South Africa 83.6 80.4 -3.2
28 Tanzania 72.9 60.8 -12.1
29 Togo 41.7 52.9 11.2
30 Uganda 82.7 58.5 -24.2
31 Zambia 56.1 81.6 25.5
32 Zimbabwe 88.9 73.0 -15.9
Table 2. 
Percentage of women currently using modern contraceptive methods who received their most recent supply or 
information from a public source, DHS surveys [66].
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Sub-Saharan Africa has the highest overall discontinuation rates due to all 
reasons, ranging from 19.1% in Namibia to 65.5% in Guinea [66]. In this analysis, 
five out of twelve countries have experienced an increase in discontinuation rates. 
All except Nigeria with a rate of 13% had these rates less than 5%. Senegal recorded 
massive decline in discontinuation rate or negative 15.9% (or −15.9%) (Figure 3). 
However, at a global level, the lowest discontinuation is recorded in Papua New 
Guinea with a rate of rate 15.6% [80].
Concerning method switch, the same twelve countries were involved due to a 
variety of reasons enumerated above. Four countries recorded increases in the rates 
of switching, while the remaining experienced declines of up to 6.3% (or −6.3%) 
(Table 3). Rate of discontinuation due to desire to become pregnant declined in 
three countries, while Nigeria and Republic of Benin recorded the largest increases 
of up to 4.5% each (Table 4).
Discontinuation due to side effects declined in four countries but increased in 
the remaining eight (Table 5). The largest increase was recorded in Nigeria, 5.1%. 
Discontinuation due to health-related factors could be an indicator of quality of 
family planning services.
Country Recent Earliest Change
Benin 2.5 1.5 1.0
Burundi 4.6 8.1 −3.5
Ethiopia 5.8 12.1 −6.3
Kenya 10.5 7.0 3.5
Malawi 5.3 3.7 1.6
Mali 1.9 3.4 −1.5
Nigeria 4.5 4.8 −0.3
Rwanda 10.3 10.4 −0.1
Senegal 4.2 5.2 −1.0
Tanzania 6.4 9.4 −3.0
Uganda 5.0 5.2 −0.2
Zimbabwe 6.7 4.2 2.5
Table 3. 
Percentage of women currently using modern contraceptive methods who discontinued by switching to another 
method, DHS surveys.
Figure 3. 
Change in the first-year contraceptive discontinuation rate due to all reasons, DHS surveys.
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6. Factors associated with the use of modern contraception
The current body of knowledge is replete with literature on the factors associ-
ated with the use of modern contraception. Systematically, these factors are 
grouped into two broad categories:
1. Individual factors
2. Contextual factors
Country Earliest Recent Change
1 Benin 7.7 12.2 4.5
2 Burundi 9.0 9.2 0.2
3 Ethiopia 10.3 10.8 0.5
4 Kenya 4.6 4.7 0.1
5 Malawi 8.4 6.7 −1.7
6 Mali 13.8 14.8 1.0
7 Nigeria 8.2 12.7 4.5
8 Rwanda 2.7 3.9 1.2
9 Senegal 7.3 6.3 −1.0
10 Tanzania 8.4 5.1 −3.3
11 Uganda 7.5 8.8 1.3
12 Zimbabwe 4.8 5.1 0.3
Table 4. 
Percentage of women currently using modern contraceptive methods who discontinued due to desire to become 
pregnant, DHS surveys.
Country Earliest Recent Change
1 Benin 5.9 5.8 −0.1
2 Burundi 10.6 15.2 4.6
3 Ethiopia 14.5 7.4 −7.1
4 Kenya 8.5 10.5 2.0
5 Malawi 10.5 10.6 0.1
6 Mali 10.3 10.5 0.2
7 Nigeria 2.1 7.2 5.1
8 Rwanda 10.7 10.8 0.1
9 Senegal 14.2 11.3 −2.9
10 Tanzania 11.6 9.8 −1.8
11 Uganda 15.8 18.1 2.3
12 Zimbabwe 3.6 6.0 2.4
Table 5. 
Percentage of women currently using modern contraceptive methods who discontinued due to side effects, DHS 
surveys.
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6.1 Individual factors
Education of the woman appeared as a strong and consistent predictor of contra-
ceptive uptake. Across many studies, women with higher level of education reported 
current use of modern contraception compared to those with none or lower level 
[81–84]. Educated women are more likely to use modern contraception because it 
facilitates several pathways to use contraception. For instance, educated women are 
more likely to know where to access contraception and also more likely to be financially 
empowered to purchase if the need warrants. By giving her the financial and decision-
making autonomy, education gives the woman the confidence to engage her spouse 
(husband) on discussing the need to use contraception for social, fertility and medical 
reasons. Age of the woman has also been found to play an important role in modern use 
of contraception. Younger women were found to be using less of contraception par-
ticularly if they had had no living children [79]. It is the desire of every woman to bear a 
child immediately after getting married most especially in high-fertility countries. After 
achieving the desired number of children, the use of contraception increases [85, 86]. 
Women who perceived their husband’s disapproval of contraception are unlikely to use 
it partly due to cultural dominance of the husband as the sole decision-maker [72, 87]. 
Male partner involvement has been shown by numerous studies to positively increase 
use of contraception by women [88]. Also, positive male attitudes toward family plan-
ning have been reported to influence the use of contraception both from cross-sectional 
questionnaire and focus group discussion studies [89, 90]. Other individual-level char-
acteristics reported to influence use of modern contraception include being employed 
[81, 84], religion [91–93] and spousal communication [72, 92].
6.2 Contextual factors
Broadly, the contextual factors considered here include socio-cultural, economic 
and health systems, specifically, place of residence, household economic status, 
social networks, accessible health facilities and/or health care workers providing 
contraception.
Women residing in urban areas have an advantage through both improved 
access to variety of contraception and being exposed to information channels that 
could positively influence utilization [92]. This urban advantage is also linked to 
average higher educational level of the women in urban areas as well as accessibility 
and being aware of facilities (both public and private) providing family planning 
services dotting the urban areas [71, 94, 95]. Household wealth level has also been 
reported to positively influence uptake of contraception. With higher household 
economic status, women are most likely to overcome cost-related barriers to the 
commodity and hidden cost of transportation and opportunity cost to obtain 
contraception [83]. Strong social networks among men that encourage and sup-
port use of modern contraception are a significant factor in increased use among 
the wives of these social networks [82, 96]. Other contextual factors known to 
positively increase contraceptive uptake include available and accessible facilities 
providing family planning services [70, 92, 97], visit by a health care worker or 
having a discussion with health care worker on contraception [98], cultural norms 
concerning fertility and contraception [92, 99, 100].
7. Conclusion
Understanding the factors beyond the individual and household characteristics 
that affect utilization and household characteristics that affect utilization of these 
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Chapter 4
Planning Methods in Ecuador’s
Indigenous People
Yaroslava Robles-Bykbaev, Nina Naula, Javier Cornejo-Reyes,
Ana Parra, Vladimir Robles-Bykbaev, Blas Garzón
and Jorge Galán
Abstract
Sexual and reproductive health (SRH) is a fundamental human right that implies
knowledge and exercise of sexual and reproductive rights (SSR). Among the latter
are access to knowledge and use of contraceptive methods; therefore, SSR should be
experienced as a constant experience that allows women to achieve full satisfaction
and security in their sexual and reproductive sphere through their subjectivity, their
body, and their social and cultural life. Knowing about family planning allows
having the desired number of children determining the interval between pregnan-
cies and choosing the contraceptive method according to the social, cultural and
psychological beliefs, needs and conditions of each woman. However, indigenous
women from Canton Cañar (Ecuador) have less access and knowledge to contra-
ceptive methods, mainly due to the influence of social, cultural, religious and
economic factors, among others. The lack of information about family planning in
indigenous populations of the South of Ecuador has motivated this study; through a
medical-anthropological approach, it is intended to determine what is the prefer-
ence regarding contraceptive methods in indigenous Cañari women in the context
of the Cañari culture and what are their perceptions regarding such methods.
Keywords: planning methods, indigenous peoples, Cañari population,
indigenous women, Ecuador
1. Introduction
Health is a fundamental human right, SRH is a part of health, and this gives the
reason for SRR to also be a fundamental human right [1]. The term “reproductive
rights” was made public at the First International Conference on Women’s Health
carried out in Amsterdam, Holland, in 1984 [2], whereas the term “sexual rights”
was introduced as a negotiation strategy at the International Conference on Popu-
lation and Development (ICPD) in 1994, with the purpose of guaranteeing the
inclusion of reproductive rights in the final version of the El Cairo Declaration and
Action Program [2]. In 1997, the World Declaration of Sexual Rights was formu-
lated at the World Congress of Sexology (Valencia-Spain). It was later ratified at the
General Convention of the Sexology Association (WAS) during the XV Sexology
Congress carried out in Paris.
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The Organización Mundial de la Salud (OMS) [3] declared that sexual health is a
state of physical, mental and social welfare related to sexuality. It demands a posi-
tive and careful treatment of sexuality and sexual relations, as well as the possibility
of having pleasant and safe experiences that are free from coercion, discrimination
and violence. The OMS precept on sexual health is exclusive, biased and oriented
toward the western paradigm, since it does not correspond to the local reality of the
Original Peoples of Ecuador such as the Cañari, determined by bio-psycho-socio-
cultural factors and economics such as ethnicity (especially indigenous and mes-
tizo), religion (Catholic, Christian, Evangelical and charismatic groups, among
others), literacy, social class, level of education, work activity and profession,
among others. The aforementioned factors determine the way and lifestyle of the
indigenous women of Cañar, their perception of SRH and the cultural imagery
through which social construction on the use of contraceptive methods takes place.
The ways and lifestyles of Cañari women have a direct “relationship with the
land and fertility, as well as with physical spaces considered feminine,” since they
are assigned for physical and social reproduction in the community [4]. This task of
reproduction prevents access to free-form contraceptive methods if they are single
[5] or adolescents (18 years), since they are frowned upon by the community and
are stigmatized. Therefore, the religious and cultural precepts of the Cañaris com-
munities are focused on control [6] regarding the exercise of their SRR.
Cañari indigenous adolescents and young adult women have greater difficulties
in accessing knowledge and care in contraception due to the taboo issue that SRH
represents, but also due to traditional paradigms on the role of sexual reproduction,
since in indigenous communities of the Ecuador the idea that sexuality is reserved
for reproduction still prevails, and the generational continuities crossed by the
power relations of the gender system are reinforced [7–9]. Specifically, because the
house is considered a sacred and immutable group of male ancestry that controls
access and management of symbolic reproduction related to fertility [10], and sub-
ordinates the symbolic representation of women towards the Nature, therefore, is a
generator of life and a naturally reproductive subject [11].
Within the value system of the Cañari culture, the generational hierarchy within
the female gender plays a fundamental role, since respect from one generation to
another forbids the dialog between mothers and daughters about the use of contra-
ceptive methods, due to a generational role assigned to women according to their
life cycle. Therefore, it is forbidden to talk about sexuality and birth control
methods (“take care” in terms of the indigenous community of Cañar) among older
adult women, and young adults and adolescents.
Not being able to talk freely between women of one generation (adolescents and
young adults) and those of another generation (mature adults and older adults) may
be related to modesty as an acetic value within the value system of the Cañari
culture governed by the influence of religion. Indeed, modesty is related to a form
of social control mainly for the censorship of what is related to sexuality, therefore
chastity, and also for its erotic connotation [12–14]. In other words, modesty plays a
role as a sobering element for the redirection of indigenous sexual behavior, since it
allows values such as dignity and honor to be achieved [15].
Shyness as a social value allows to build and achieve a stereotype of biological
and social woman; therefore, it is through the body of indigenous women that the
experience of social control of modesty or embodiment1 is manifested, so that this
body is the existential basis so that said social control can be generated and
1 It consists of living, with and through the human body, a set of emotions and sensations we experiment
throughout our lives [16].
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reproduced collectively through the intersubjective experiences [17] of the Cañari
culture. In the case of the indigenous women of Cañar, modesty in relation to body
management has its essence in the tendency to hide sexual values so as not to turn
the body into an object of pleasure [18] without permission and theocratic recogni-
tion of religion, for example, Catholic, Christian and Evangelical, among others,
through consecrated union in the church (ecclesiastical marriage).
Body shame or embarrassment arises as a result of the body, since it occurs in
relation to some aspect of the body or body management [19]; specifically, the
female body continues to be a place of shame for women; it is associated with
passions and uncontrolled appetites and with something dirty and polluting [20].
That is, it constitutes the social, biological and cultural site where the intersubjec-
tivities of mature and older women, families, men and subjects of the indigenous
Cañari society discipline it, and thus socially control the behavior of adolescent and
young adult women, as well as single, divorced or separated women to prevent
them from experiencing sexuality related to family planning. Since the female body
that has not been sacralized through ecclesiastical marriage, and by the mere fact of
being a female body, becomes an impure space.
Currently, the society of the Cañari culture still exercises social and biological
control in the body of the indigenous women of Cañar, that is why Cañari society
can accept birth control for women, as a normative and socially accepted behavior,
only if women are married. This phenomenon already took place in Quito, Ecuador,
in 1970 [21], since the main group of attention for family planning was women who
already had children, most of them married, which reaffirmed the exercise of
sexuality only under the conjugal mandate. According to the Organización
Panamericana de la Salud (OPS) and the Comisión Económica para América Latina
y el Caribe (CEPAL), in Ecuador, between 67% and 90% of indigenous youth reside
mostly in rural areas, and they also have social exclusion, determined by schooling
(4–6 years of study approved) [22]. Being a young indigenous woman and residing
in a rural sector together with having an early active sexual life will become indica-
tors of risk for SRH, exclusion, poverty and difficulty for living conditions.
The start of an active sexual life of teenagers at an early age implies risks such as
unwanted pregnancy, sexually transmitted infections, clandestine abortions and
social segregation, among other problems. It is estimated that in Latin America 50%
of young people under 17 are sexually active [22]. In fact, in Ecuador, teenagers’
sexual relations start at the age of 15 [23, 24]. In the case of teenagers’ fertility
(15–19 years old), an alarming increase of 11% between 1999 and 2004 and
between 2007 and 2012 [25] has been observed in Ecuador.
In most nonwestern countries, and especially in indigenous contexts, women
reach the state of biological and social adulthood with marriage and motherhood at
a stage in life that—according to western chronological criteria—could be catego-
rized as adolescence. In this way, the right to marry is connected to biological
maturity in traditional societies [22]. Despite the fact that in indigenous communi-
ties the acquired right to access family planning is instrumentalized and admitted
by marriage, women do not have the same freedom to exercise their SRR, including
that of family planning.
Teenage women, young adults and single mature adults who choose a family
planning method are socially singled out. Well, sexuality is repressed, since sexual
relations before marriage is seen as a lack of honor and a risk for women [26].
Therefore, the women’s body is relate to something dirty and polluting, for that
reason that mentioned body plays again a fundamental role as a social and biological
space for socialization of the experience of cultural values. In other words, the
passions and and uncontrolled appetites that those women can have must be social
controlled by the Cañari culture. Even more so, if they are single indigenous
women, they are socially stigmatized or singled out; in fact, according to the
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reproduced collectively through the intersubjective experiences [17] of the Cañari
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(15–19 years old), an alarming increase of 11% between 1999 and 2004 and
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a stage in life that—according to western chronological criteria—could be catego-
rized as adolescence. In this way, the right to marry is connected to biological
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ties the acquired right to access family planning is instrumentalized and admitted
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Therefore, the women’s body is relate to something dirty and polluting, for that
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Ministerio de Salud Pública del Ecuador (MSP), this social phenomenon stands out,
since single mothers are the target of aggression and contempt in the community;
and girls are physically and psychologically punished and are often expelled from
home and from the community [27].
For their part, married indigenous women who have children can opt for family
planning; in addition, society assigns the role of motherhood as a central component
of their existence and socially grants them prestige and social recognition [27]. We
will then say that the prevailing cultural system, the model of social control based
on religious asceticism, the generational hierarchy in the female gender, patriarchal
domination and belonging to the indigenous ethnic group in localities of Cañar
influence access to knowledge and care in SRH and SSR, and therefore access to
family planning methods.
According to OMS [3], it is calculated that, at world level, 214 million women of
childbearing age in developing countries want to postpone or stop procreation, but
they do not use any modern contraceptive method. However, in Ecuador, according
to INEC [28, 29], the indigenous population has the lowest knowledge of contra-
ceptive methods (34.7% of a total of 221.558). Regarding the prevalence of contra-
ceptives and demand for satisfactory family planning [30], a more substantial
dependence on traditional methods is observed in Ecuador in women aged 15 to 49.
In the case of contraceptive methods, indigenous women prefer the use of rhythm
or calendar (24.6%), ligature (23.6%), IUD/IUS (copper spiral “T”) (19.1%), injec-
tion (16.4%), abstinence (6.7%), contraceptive pill (5.3%) and, finally, condom
(3.9%). From their part, mestizo women prefer tubal ligation or female sterilization
(35.9%), contraceptive pill (18.7%), rhythm (15%), IUD/IUS (14%), injection
(9.5%), condom (4.2%) and abstinence (1.2%).
The rhythm method is currently not recommended or is proscribed as being
ineffective [31]. Furthermore, the fact that indigenous women prefer such a con-
traceptive method is a trend that reflects less access to knowledge and family
planning. The preference for tubal ligation and the preference for the rhythm
method reveal the place that women occupy with regard to the subject of rights
[32]; however, the strong religious influence reflects how women, indigenous peo-
ple and their partners consider the use of contraceptive methods as a sin, and for
their part, men consider that their partners can return to being adulterous [33].
1.1 Some data about the province and city of Cañar
In the province of Cañar (located in southern Ecuador), 15.2% of its population
identifies itself as indigenous, while 76.7% identifies itself as mestizos [34]. It is a
culturally representative province of Ecuador regarding customs, history and
archeological remains. In the Cañar canton (located in the Cañar Province in the
south of the country), there are 12 parishes: Cañar, Chontamarca, Chorocopte,
Ducur, General Morales, Gualleturo, Honorato Vásquez, Ingapirca, Juncal, San
Antonio, Ventura and Zhud.
According to the Municipio Intercultural del Cañar [35], this canton has around
58,185 inhabitants, and 40% of the population is indigenous, represented mainly by
the Cañari ethnic group. The Cañari people speak Kichwa and Spanish. The identi-
ties of each indigenous people of the Cañari culture take place through the colonial
present, but also with some influence from the pre-Inca past [36]. Furthermore,
expressions, manifestations and their cultural value system are subject to
resignifications due to processes of cultural syncretism.
In 2015, according to the Secretaría Nacional de Planificación y Desarrollo
(SENPLADES) [37], the illiteracy rate for the indigenous population of the Cañar
Province represented 42.78% and the poverty rate 95.2%. According to CEPAL [38],
64
Family Planning and Reproductive Health
in 2001, the global fertility rate was 4.6 in the indigenous population in the province
of Cañar, while for 2015, according to (SENPLADES), the number of teenage
pregnancies (15–19 years) in Cañar [37] reached 11% in the province of Cañar.
With the exposed background about cultural phenomenology, which has
allowed to partially understand how the perception of sexuality takes place and, as a
part of it, how the indigenous women of Cañar manage family planning, our
interest is to determine their preferences regarding contraceptive methods, consid-
ering the fact that there is scarce information about it. For this purpose, a
descriptive-exploratory study was conducted (diagnosis phase) that focused on
determining the perception indigenous women, aged 19–59, of the rural areas of
Juncal and Ingapirca and the urban area of Cañar have about the use of and prefer-
ence for contraceptive methods.
2. Methodology and design
This was a descriptive-exploratory study because information about family
planning in the indigenous communities located to the South of Ecuador, such as
Cañar, is scarce and insufficient, especially due to their biological position.
Data gathering was done by administering a previously validated survey through
the Cronbach’s alpha test (0.7). This survey was administered in the city of Cañar in 3
occasions during 3 months, considering the fact that SRH is a taboo and reaching a
quotient of Cronbach’s alpha higher than 0.7 was not possible. As previously stated, on
the one hand, it is necessary to consider the difficulty of accessing a social construct
about SRHwithin the system of values of this population. On the other hand, this is an
exploratory study (diagnosis phase or baseline) and there is not enough information
about this population’s preferences regarding birth control methods, and due to the
structure of their cultural system and cosmogony, access to information is restricted
by the marked complexity that the cultural construct of sexuality represents. For this
reason, it was decided to work with a quotient of Cronbach’s alpha of 0.7.
Sampling was done randomly to 25 women who identified themselves as indig-
enous. It was checked that they had a level of elementary, high school and higher
education. The surveys were applied in high social activity strategic zones in three
parishes: Cañar (urban), Ingapirca and Juncal (rural). Additionally, accessing to the
next parishes was easier (see Table 1), considering the fact that, in general, it is not
easy to gather information in indigenous communities because local and/or foreign
researchers usually get data but people disapprove of this:
• In the community of Yaculoma, which belongs to the parish of Juncal, surveys
were applied to indigenous women attending the Unidad Educativa
Intercultural de Juncal.
• At the cattle square and the clothes market of the urban parish of Cañar.
• At the community of Vendeleche belonging to the parish of Ingapirca.
The majority of the Cañari indigenous women interviewed belong to the par-
ishes of Ingapirca (10) and Cañar (8) (see Table 1) and they speak both languages:
Spanish and Kichwa.
The analysis of information was done by using “R” open software, version 1.1.456.
A descriptive statistical analysis was done (measurements of central and dispersion
tendency) because it was necessary to start with a diagnosis phase of the preference
the indigenous women of the city of Cañar have regarding the use of contraceptives.
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Surveys were applied to volunteer indigenous women of Cañar of any marital
status, aged 19–59, with a level of elementary, high school or higher education.
Volunteer participants signed the informed consent before participating in this
study. Surveys were applied by a previously trained team of women, and one of the
team collaborators was a Kichwa native speaker and supported the rest or the team
to access the communities.
3. Results
It is worth mentioning that the results obtained should be considered taking into
account several variables: age, marital status, years of study, the level of education
and current occupation, and also, all respondents were indigenous and Catholic.
The age range of respondents was between 19 and 59 years. It was observed that
the average pregnancy per woman was 3.08, and the pregnancy range was from 0 to
8 children, 2.72 being the average. Regarding the level of education of respondents,
15 women had elementary school education, 3 women had high school instruction
and 7 had a higher education degree. In relation to their marital status, 22 women
were married, 1 woman had free union relationship and 2 were single.
We asked some questions in order to understand what is the preference
regarding contraceptive methods in Cañari indigenous women and what are their
perceptions regarding such methods:
1.How many children do Cañari indigenous women have?
2.What is the most widely identified contraceptive method by the indigenous
women of Cañar, according to the community they are from, their level of
education and age?
Parishes Communities Indigenous women Total %




Chorocopte La Capilla 2 4 16
Tretón 2
El Tambo Coyoctor 1 1 4
Gualleturo Gasa 1 1 4
Honorato Vásquez Sigsihuayco 1 1 4







The table shows the Cañaris parishes were the surveys have been applied to indigenous women.
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3.What family planning method is the most widely used and which age group of
women prefers this method?
4.How many children do women who have generally had tubal ligation have,
how old were they when they decided to have tubal ligation and what is their
level of education?
5.What is the age to begin the use of contraceptives in Cañari indigenous
women, and why?
It is important to mention here that the results obtained showed that the women
were engaged in the following activities: farmer (28%), housewife (40%), merchants
(8%), public servant (8%), teacher (8%), physiotherapy assistant (4%) and student
(4%). The 80% of housewife women respondents and the 100% of the farmer
women respondents have elementary school education. The Cañari indigenous
women respondents above mentioned belongs to the communities of Cañar (8),
Chorocopte (4), Tambo (1), Gualleturo (1), 14 Honorato Vásquez (1) and the parish
of Ingapirca (10) (see Figure 1).
3.1 How many children do Cañari indigenous women have?
Women having a higher number of children are those who have elementary
school education, especially indigenous women between 49 and 59 years old (see
Table 2), probably due to the fact that only 193.5 (estimated number in thousands)
cases of sterilized women between 15 and 49 years old were registered in Ecuador
until 1987 [39]. For this reason, women living in rural areas of Ecuador in the 1990s
(30 years ago) did not know much about tubal ligation as a contraceptive method.
Consequently, it was not a well-known birth control option; on the other hand, it
was fundamental to have large families so that children can contribute to
Figure 1.
The panel shows how indigenous women have been categorized according to their marital status, scholarity,
current occupation and community. As Table 1 shows, most women are married and have elementary school
and higher education, are from the communities of Cebadas and Coriurco, and are farmers.
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agricultural and livestock tasks, especially in rural areas. Currently, there are still
indigenous communities in Cañar, where women having a higher number of
children, that is, between 5 and 8 children, are those from the rural parishes of
Cebadas, Cochapamba, Coriurco and Gasa, and they have between 5 and 6 years of
education (elementary school), while single women or women who have a free
union relationship have 1 child and are from Chuguin Grande, Cebadas and
La Capilla (see Figure 2).
3.2 What is the most widely identified contraceptive method by the indigenous
women of Cañar, according to the community they are from, their level of
education level and age?
The two most widely known contraceptive methods by the Cañari indigenous
women between 19 and 59 years old are tubal ligation (24%) and hormonal injection
(24%), followed by the contraceptive pill (16%) and no method (8%). It is impor-
tant to say that Cebadas is the community that most identify contraceptive methods













19–28 Free Union 1 (1.47%) 10 (14.71%)
Married 2 (2.94%) 5 (7.35%) 1 (1.47%)
Single 1 (1.47%)
29–38 Married 3 (4.41%) 11 (16.80%) 14 (20.59%)
39–48 Married 5 (7.35%) 21 (30.88%) 26 (38.24%)
49–59 Married 2 (2.94%) 16 (23.53%) 18 (26.47%)
12 (16.76%) 54 (79.41%) 2 (2.94%) 68 (100.0%)
Table 2.
Number of children that indigenous women of Cañar have according to age group and education level.
Figure 2.
Number of children that Cañari indigenous women have according to level of education and civil status.
68
Family Planning and Reproductive Health
Tubal ligation, for its part, has been identified as an inexpensive method, which
is easy to access, allows family planning and avoids teenage pregnancy. Cañari
indigenous women also say that it is easy to access hormonal injections, which
allow family planning and avoid teenage pregnancy. Regarding contraceptive pills,
indigenous women know about the last two advantages indicated above. There is
also the perception that not using a contraceptive method is inexpensive. Finally,
pills and/or hormonal injections are considered to be inexpensive and comfortable
(see Figure 3).
3.3 What family planning method is the most widely used and which age group
of Cañari indigenous women prefers this method?
The contraceptive methods the indigenous married women of the city of Cañar
who were surveyed prefer are tubal ligation (36%), none (28%), injections (12%),
implants (12%), contraceptive pill (8%) and rhythm method (4%). The community
where contraceptives are most widely used is Cebadas (24%) (see Table 4). It must
be considered that most respondents were married (22–25 years old; see Table 1).
This is worth noticing because single women did not want to participate to avoid
being identified and stigmatized and criticized by the people of the community, as
it was stated in the theoretical section of this discussion. It is also necessary to
highlight that all the respondents declared themselves to be Catholic and, as it was
Contraceptive methods Elementary school High school Higher education Total
All 1 1
Hormonal injection 5 1 6
Various 1 2 1 4
Implant 1 1
IUD/IUS 1 1
Pill 1 3 4
Tubal ligation 6 6
None 1 1 2
15 3 7 25
Table 3.
Contraceptive methods identified by Cañari indigenous women.
Figure 3.
Notice that the indigenous women of Cañar know about hormonal injection and/or tubal ligation, as well as
implants, as valid options to avoid teenage pregnancy, IUD/IUS as a method that allows them to work, and
hormonal injection and/or implants as methods that allow them to plan their pregnancies.
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stated before, they have a system of social control; therefore, women’s sexuality is
also controlled.
Accessing contraceptive methods is considered to be easy for most women who
are married, have a free union relationship, or are single. However, married women
represent most of the sample of the respondents (22). Notwithstanding, in this
group, women from the parishes of Gasa, Quilloac and Sisid consider that accessing
contraceptive methods is difficult or very difficult (see Figure 4).
Married women (with elementary school and higher education level) think that
the community has to condemn the behavior of single women who use contracep-
tive methods, as well as they have the perception that this will turn out to be a
shame for families. Finally, they consider that the partners of single women who
start contraception criticize them. This perception phenomenon is reproduced by
women who have a free union relationship. Single women preferred not to answer,
which may be associated to the stigma we talked about in the introductory theoret-
ical part of this discussion (see Figure 5).
The family planning methods that Cañari indigenous women prefers are: 17
tubal ligation (50%), followed by hormonal injection (16.6%), implant (16.6%), 18
and pill (16.6%), pill (11.1%), and rhythm method (5.55%).
Women between the ages of 39 and 48 have more frequently had tubal ligation
(24%), but women between the ages of 29 and 38 (16%) show also this phenomena,
while women between the ages of 49 and 59 represent 4%. Young adult women
Contraceptive methods Single Free union Married Total
Hormonal injection 3 3
Implant 1 1 1 3
Pill 2 2
Rhythm method 1 1
Tubal ligation 9 9
None 1 6 7
2 1 22 25
Table 4.
Contraceptive methods used by Cañari indigenous women.
Figure 4.
This figure shows Cañari indigenous women’s access to contraceptive methods.
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(19–28 years old) usually choose methods like hormonal injection, implant and
contraceptive pill (28%), probably because they are temporal long-term methods
and they still want to have children.
About 28% of Cañari indigenous women do not use any contraceptive method,
and this is probably caused by their low level of education, since women in all the
age groups (19–28, 29–38, 39–48 and 49–59) that do not use any kind of contracep-
tive method have elementary or high school education. On the contrary, women
who more widely use contraceptives, besides being young (19–28 years old), are
those who have elementary school education (see Table 5).
The social phenomenon of prevalence of use of contraceptive methods similarly
corresponds to women who have elementary school education. On the other hand,
in the case of young women who do not use any contraceptive method and have
elementary and high school education, the phenomenon is also related to the num-
ber of children they have: the higher the level of education they have, the fewer the
number of children they have.
Figure 5.
This figure shows Cañari indigenous communities’ perception about single women’s use of contraceptives.
Contraceptive methods Age Elementary High school Higher education Total
Hormonal injection 19–28 2 1 3
Implant 19–28 1 1 1 3
Pill 19–28 1 1
39–48 1 1
Rhythm method 29–38 1 1
Tubal ligation 29–38 1 2 3
39–48 4 1 5
49–59 1 1
None 19–28 1 1 2
29–38 1 1 2
49–59 2 1 3
Table 5.
Prevalent use of contraceptive methods by Cañari indigenous women according to their level of education and
age.
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3.4 How many children do Cañari indigenous women who have generally had
tubal ligation have, how old were they when they decided to have tubal
ligation and what is their level of education?
We can see that Cañari indigenous women who have a higher level of education
have fewer number of children. Ligation as a method of family planning prevails in
the indigenous women of Cañar who have between 5 and 6 children. However,
having 8 children in the current era is not prevalent. That is why, only 1 woman had
a ligation when having this number of children (see Figure 6).
Respondents perceive that both the women they interact with and other women
of the community who have undergone tubal ligation consider it to be “very dan-
gerous” (20% and 44.4%). However, other women in these two groups consider
tubal ligation to be “very safe” when their close acquaintances have undergone
tubal ligation (40%) and also when their close acquaintances have not undergone
tubal ligation (33.3%). Similarly, some women consider tubal ligation to be danger-
ous for their health, harmful for their bodies and the cause of abdominal pain.
Finally, they say it weakens their bodies (6.7%), and surveyed women believe that
tubal ligation is a sin (6.7%) (see Figure 7).
Figure 6.
Prevalent use of tubal ligation by Cañari indigenous women.
Figure 7.
The figure shows Cañari indigenous women’s perception about tubal ligation when their close acquaintances
have undergone tubal ligation.
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3.5 What is the age to begin the use of contraceptives in Cañari indigenous
women, and why?
Cañari indigenous women’s perceptions about reasons to begin the use of con-
traceptives at age 17 in adolescents (see Figure 8) is very concerning, because they
are too young, and it shows that in this community sexual activity starts very early.
This is very dangerous not only because it predisposes them to sexually transmitted
infections (STIs), unwanted pregnancy and abortion, but also because their adoles-
cence is reduced, and their adulthood starts early.
4. Conclusions
Based on the results obtained, we can state that the number of children the
indigenous women of Cañar have, as it is already known, is connected to their level
of education. This research has proven that the higher the number of children these
indigenous women have, the fewer the years of education they have (inversely
proportional) (see Table 5).
The two contraceptive methods that are most widely identified by the indigenous
Cañari people between the ages of 19 and 59 are tubal ligation (24%) and hormonal
injection (24%), followed by the contraceptive pill (16%), no known method (8%),
and, finally, hormonal injection/implant (4%), hormonal injection/tubal ligation
(4%), implant (4%), IUD/IUS (4%) and all the rest (4%) (see Table 3).
Women having a higher number of children (5–8) are from the rural parishes of
Cebadas, Cochapamba, Coriurco and Gasa and have 5 or 6 years of education
(elementary school), while single women or women who have a free union
relationship have 1 child and come from Chuguin Grande, Cebadas and La Capilla
(see Figure 2).
Tubal ligation is definitely the preferred contraceptive method (see Table 4) by
women aged 29–59 (50% of all the family planning methods), including both
women having elementary school education (higher number of children) and high
school education (fewer number of children). This is defined by the social
Figure 8.
Respondents with elementary school level education perceive that adolescents at age 17 can, and also should,
begin the use of contraceptives because adolescents have biological maturity, adolescents show social maturity,
the contraceptives avoid teenage pregnancies and they also allow to study. But respondents with higher education
level mostly perceive that adolescents should begin the use of contraceptives at age 17 because of their biological
maturity and because the contraceptives limit family size, let family planning, avoid teenage pregnancies and
allow to study.
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phenomenon of change of values within this population’s cultural system, just as the
respondents, during the survey, besides answering questions, confessed that they
decided to use contraceptive methods considering the fact that they help to improve
both their economy and their children’s quality of life. Also, they think that tubal
ligation offers several advantages: it is inexpensive and is easy to access, and it
allows family planning and avoids teenage pregnancy (see Figure 3). However,
young women (19–28 years old) choose other methods: hormonal injection, implant
and contraceptive pill (28%), considering the fact that they are long-term temporal
methods and probably still want to have children.
Besides, tubal ligation was perceived by the surveys as “very dangerous,” “very
safe,” “dangerous for health,” “harmful to the body,” “causes abdominal pain” and
“weakens the body.”
It is important to highlight that 28% of Cañari indigenous women do not use any
contraceptive method. They are the women who have elementary or high school
education. Again, it corresponds to the inversely proportional relationship: the higher
the level of education, the fewer the number of children. Choosing natural or tradi-
tional contraceptive methods is also connected to “sin,” this being the reason that
some women value this behavior so as not to break this cultural and religious standard.
In general, accessing contraceptive methods, according to the survey results, is
very easy, considering the fact that the Cañari indigenous women who participated
in the survey were married (22) (see Figure 4). Single women did not want to
participate in the survey due to the fact that their marital status limits their answers
because they are the target of criticism, as it was indicated in the introductory part
of this discussion. For this reason, married women know that their communities
condemn the behavior of single women who use contraceptive methods. They also
believe that it is a shame for the families of those women, and they think the
partners of single women who start using contraceptive methods speak ill of them
(see Figure 5). The target of criticism that is embodied in single women who use
contraceptive methods or participated in the survey is related to shyness or the
female stereotype. That is, through the indigenous women’s bodies, social control of
shyness is manifested in such a way that it becomes the existential basis of shyness.
The strong influence of the social control exercised by religion is another important
factor. In this study, all the surveys show that these women are Catholic and, as it
was stated in the introductory theoretical part of this discussion, the religious
component is a system of social control and, consequently, also controls women’s
sexuality, which is expressed through their bodies.
We need to state that the Cañari culture is marked by a system of values where
religion plays the role of socially controlling women’s sexual behavior and embodies
the stigma of accessing contraceptive methods through a woman’s body. This is
lived as a set of experiences that modifies these women’s access to contraceptive
methods and, consequently, to family planning. We can also say that the number of
children women having a low level of education have is a factor that determines the
occurrence of the previous phenomenon. The fact that some mature adult women
undergo tubal ligation is another important factor that needs to be paid attention to.
Before 1990 (1987), a record of tubal ligations of women between the ages of 15 and
49 in Ecuador shows the lack of knowledge of this contraceptive method in rural
communities; consequently, it was not considered to be a birth control and/or
family planning option.
Finally, we also state that there is very concerning the beginning of the contra-
ceptives use in cañari indigenous adolescents (see Figure 8) because they start
sexual activity very early, and predisposes them to sexually transmitted infections
(STIs), unwanted pregnancy and abortion; but, also because their adolescence is
reduced, and their adulthood starts before.
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In recent years, multiple pregnancy rates have increased significantly. Twin 
pregnancy rate increased by 76% between 1980 and 2009, from 18.9 to 33.3 in 1000 
births. Triplets and high-order multiple pregnancies have increased by 400% in 
the 1980s and 1990s. Two main reasons of this increase in the incidence of multiple 
pregnancies are: (1) maternal age at the time of conception, shifting to advanced 
ages where multiple pregnancies are more common and (2) a more common use 
of assisted reproductive techniques. The main problem in multiple pregnancies is 
spontaneous preterm delivery and associated neonatal morbidity and mortality. 
Although numerous attempts have been made to prolong the gestation period and 
improve outcomes, none of them have been effective. In this article, the complica-
tions encountered in multiple pregnancies will be summarized and evidence-based 
approaches that can be used in their management will be reported.
Keywords: twins, triplets, monozygotic, dizygotic
1. Introduction
Multiple pregnancy rates have increased significantly in recent years. The twin 
pregnancy rate increased from 18.9 to 33.3 per 1,000 births between 1980 and 
2009, increasing by 76% [1]. Multiple pregnancies with triplets and higher numbers 
increased by 400% in the 1980s and 1990s [2]. There are two main reasons for this 
increase in the incidence of multiple pregnancies: (1) Maternal age at the time of 
conception is shifting to advanced ages with multiple pregnancies and (2) a more 
common use of assisted reproductive techniques [3].
The main problem encountered in multiple pregnancies is spontaneous preterm 
labor and associated neonatal morbidity and mortality. Although several attempts 
have been made to prolong the duration of these pregnancies and improve out-
comes, none of them have been effective. In this chapter, the complications encoun-
tered in multiple pregnancies will be summarized and evidence-based approaches 
that can be applied in their management will be reported.
2. Fetal and neonatal morbidity and mortality
Due to complications caused by preterm labor, stillbirth rate in multiple preg-
nancies is five times higher, and neonatal mortality rate is seven times higher than 
other pregnancies. A woman with a multiple pregnancy is 6 times more likely to 
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1. Introduction
Multiple pregnancy rates have increased significantly in recent years. The twin 
pregnancy rate increased from 18.9 to 33.3 per 1,000 births between 1980 and 
2009, increasing by 76% [1]. Multiple pregnancies with triplets and higher numbers 
increased by 400% in the 1980s and 1990s [2]. There are two main reasons for this 
increase in the incidence of multiple pregnancies: (1) Maternal age at the time of 
conception is shifting to advanced ages with multiple pregnancies and (2) a more 
common use of assisted reproductive techniques [3].
The main problem encountered in multiple pregnancies is spontaneous preterm 
labor and associated neonatal morbidity and mortality. Although several attempts 
have been made to prolong the duration of these pregnancies and improve out-
comes, none of them have been effective. In this chapter, the complications encoun-
tered in multiple pregnancies will be summarized and evidence-based approaches 
that can be applied in their management will be reported.
2. Fetal and neonatal morbidity and mortality
Due to complications caused by preterm labor, stillbirth rate in multiple preg-
nancies is five times higher, and neonatal mortality rate is seven times higher than 
other pregnancies. A woman with a multiple pregnancy is 6 times more likely to 
have a preterm delivery and 13 times more likely to give birth before 32 weeks of 
gestation [4].
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In multiple pregnancies, short- and long-term morbidity has also increased. 
Severe intraventricular hemorrhage and periventricular leukomalacia are two times 
more common in twins born before 32 weeks of gestation than in single babies 
born in the same week [5], and this explains the increased rate of cerebral palsy in 
multiple pregnancies [6].
In multiple pregnancies, still due to the prematurity, health expenses in 
both antenatal and neonatal periods are higher [7]. The spending made for 
preterm babies in the year after birth reaches 10 times the spending for full-term 
babies [8].
3. Chorionicity
Ultrasound is the reliable method to detect multiple pregnancies [9]. Ultrasound 
shows the number of fetuses, gestational week, chorionicity, and amnionicity. It is 
very important to detect chorionicity which is best assessed by ultrasound in the 
first or early second trimester.
Fetal and neonatal mortality and morbidities such as congenital anomaly, 
prematurity, and intrauterine growth restriction are much more common in mono-
chorionic twins than in dichorionic twins [10, 11]. This also applies to high number 
of multiple pregnancies; completely monochorionic or monochorionic twin pairs 
have a higher risk of developing complications compared to trichoricionic triplet 
pregnancy [12, 13]. Thus, chorionicity should be determined in the late stages of the 
first trimester or early second trimester for the management of multiple pregnan-
cies and consultancy.
4. Maternal morbidity and mortality
Medical complications such as hyperemesis, gestational diabetes, hypertension, 
anemia, bleeding, cesarean section, and postpartum depression are more common 
in women with multiple pregnancies [14–20]. These complications are managed as 
in singleton pregnancies.
The incidence of hypertensive complications is proportional to the number of 
fetuses, with 6.5% in singleton pregnancies, 12.7% in twins, and 20% in triplets [21].
In one study, it was found that the risk of developing mild or severe preeclamp-
sia in pregnancies achieved by assisted reproductive techniques was 2.1 times higher 
than other pregnancies with the same maternal age and parity [22].
Preeclampsia occurs both more frequently (relative risk 2.6) and earlier in twin 
pregnancies. This results in a higher probability of developing complications such as 
birth before 35 weeks of gestation (34.5% in twins vs. 6.3% in singles) and ablation 
of the placenta (4.7% in twins vs. 0.7% in singles) [16]. While preeclampsia is more 
common in patients with higher-order gestations, it is atypical [23]. If hemolysis, 
elevated liver enzymes, and low platelet count (HELLP syndrome) occur before 
term, the patient’s referral to the third line will be better for both the mother and 
the fetus [24].
The incidence of multiple pregnancy increases with age, regardless of assisted 
reproductive techniques. While the multiple pregnancy rate in women aged under 
20 is 16.3 per 1000 live births, this rate is 71.1 per 1000 live births in women over 40 
[2]. Regardless of the number of fetuses, obstetric complications such as gestational 





5. Effect of assisted reproductive techniques
In the past years, the proliferation of assisted reproductive techniques has led 
to a serious increase in multiple pregnancy rates [1]. In recent years, there was 
a decrease in higher-order gestation rates with the limitation of the number of 
embryos transferred in vitro fertilization (IVF) and the proliferation of embryo 
reduction. The techniques that cause the most increase in the number of multiple 
pregnancies are IVF and controlled ovarian hyperstimulation with gonadotropins. 
According to the most recent data obtained in 2010, 26% of IVF pregnancies result 
in twins, and 1.3% in higher-order gestations [25].
6. Embryo reduction and selective feticide
Embryo reduction causes a decrease in the risk of spontaneous preterm labor 
and other obstetric complications with decreased fetal number. In a Cochrane 
review, it was reported that the pregnancy loss, antenatal complication, preterm 
birth, low birth weight, and cesarean and neonatal death rates in pregnant women 
undergoing triplet-to-twin reduction were much lower than in those continuing as 
triplets and were close to the rates seen in spontaneous twins [26]. Embryo reduc-
tion in higher-order gestations also reduces the risk of preeclampsia. In one study, 
the preeclampsia incidence was 17% in pregnancies with reduction to twins and 
30% in pregnancies continuing as triplets [27].
In embryo reduction, the decision of which fetus or fetuses will be treated 
is determined according to chorionicity and easy accessibility. When one of 
the monochorionic twin pair is reduced, it is recommended that both mono-
chorionic pair be reduced, since the harmful effects on the other twin are not 
fully known.
Selective feticide is the reduction of abnormal fetus in a multiple pregnancy. The 
risk of this procedure is higher compared to embryo reduction, since it is per-
formed at a later gestational week (18th–22nd week instead of 10–12th week) [28]. 
In higher-order gestations, unwanted loss of healthy fetuses is higher than twins 
(11.2% vs. 2.4%) [29]. It was observed that gestation period was longer in pregnan-
cies without pregnancy loss [30, 31].
7. Questions and suggestions about clinic
7.1 How to determine chorionicity?
Since fetal risks depend on chorionicity, chorionicity should be determined 
as early as possible. The ideal period for the determination of chorionicity is late 
first or early second trimester. In a series, the sensitivity, specificity, and positive 
and negative predictive values of ultrasound in determining chorionicity before 
14 weeks of gestation were 89.8%, 99.5%, 97.8%, and 97.5%, respectively [32], and 
chorionicity was correctly determined in 95% of cases.
The pregnancy is dichorionic if the ultrasound shows two separate placentas or 
the gender of fetuses are different. In the case of a single placenta, the most impor-
tant ultrasound finding used to determine chorionicity is the “twin peak” finding, 
also known as “lambda” or “delta” sign. This finding shows that there is a triangular 
shaped protrusion on the chorionic surface of the placenta having the same echo-
genicity as the placenta and pregnancy is dichorionic [33].
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7.2 Is there a test to predict spontaneous preterm labor in multiple pregnancies?
In order to determine the risk of spontaneous preterm labor in asymptomatic 
pregnant women, many screening methods such as measuring cervical canal length 
with transvaginal ultrasound, examination of the cervix, fetal fibronectin screen-
ing, and home uterus monitoring have been tried. These screening methods are not 
recommended in asymptomatic women because there is no intervention that can 
prevent preterm labor in multiple pregnancies that are found to be at high risk for 
preterm labor [34].
In symptomatic pregnant women, the positive predictive value of fetal fibronec-
tin test alone or short cervical length is low and should not be used for the manage-
ment of acute symptoms [35]. Although observational studies have shown that fetal 
fibronectin or cervical canal length precludes the use of unnecessary treatment in 
singleton pregnancies with preterm labor symptoms, these data have not been proven 
by randomized controlled trials for either singleton or multiple pregnancies [36–40].
7.3 Are there any interventions to extend the duration of multiple pregnancy?
There is no evidence that interventions such as prophylactic cerclage, routine 
hospitalization and bed rest, prophylactic tocolysis, and prophylactic pessary 
reduce neonatal morbidity and mortality. Hence, their use is not recommended in 
multiple pregnancy.
7.3.1 Prophylactic cerclage
The benefit of prophylactic cerclage in a twin or triplet pregnancy without a 
history of cervical insufficiency has not been shown [41–43]. In addition, prophy-
lactic cerclage has been reported to increase spontaneous preterm labor by twofold 
in pregnant women with a short cervical canal on ultrasound (RR, 2.2; 95% [CI], 
1.2–4.0) [44, 45]. Therefore, cerclage should be avoided in multiple pregnancies.
7.3.2 Routine hospitalization and bed rest
In a Cochrane review, hospitalization or bed rest has been shown to have no 
benefit in uncomplicated twin pregnancies [46]. For this reason, routine bed rest 
should not be recommended to women pregnant with multiples due to the lack of 
benefit and the risk of thrombosis.
7.3.3 Prophylactic tocolysis
No tocolytic agent should be used for prophylaxis in multiple pregnancies. Maternal 
complications from tocolysis, such as pulmonary edema, are more common in multiple 
pregnancies [47, 48]. There are also no data that these drugs reduce the risk of pre-
term labor or improve neonatal outcomes [49–51]. Oral betamimetics did not reduce 
preterm delivery, low birth weight, or neonatal mortality in multiple pregnancies 
compared to placebo [52]. Oral betamimetics are also associated with maternal and 
fetal cardiac stress and gestational diabetes [53, 54]. It has recently been demonstrated 
to be associated with adverse maternal cardiovascular events, including death [55].
7.3.4 Prophylactic pessary
There is no scientific evidence that prophylactic cervical pessary reduces 




pregnancies. In a recent multicenter randomized controlled study, 813 twin preg-
nancies from 16 to 20 weeks were randomized [56], and poor perinatal outcome 
was observed in at least 1 baby of 13% of women treated by Arabin pessary and 14% 
of other women (RR, 0.98 CI 0.69–1.39). Therefore, the use of prophylactic cervical 
pessary is not recommended in multiple pregnancies [56].
7.4  Does progesterone treatment reduce the risk of preterm labor in multiple 
pregnancies?
Progesterone treatment is not recommended in multiple pregnancies since it 
does not decrease the incidence of preterm labor [57–63]. In one study, it was shown 
that the use of 17α-hydroxyprogesterone caproate did not reduce neonatal morbid-
ity and prolong pregnancy in triplet pregnancies [61]. In another randomized study, 
it was shown to significantly increase the rates of fetal loss in the second trimester 
in triplets [60]. In multiple pregnancies that the cervix was found to be short on 
transvaginal ultrasound, neither 17α-hydroxyprogesterone caproate nor vaginal 
progesterone has been demonstrated to be beneficial [64–67].
7.5 How to manage preterm labor in multiple pregnancies?
7.5.1 Tocolytics
Calcium channel blockers or nonsteroidal anti-inflammatory drugs are first-line 
tocolytic agents. Although there are no large-scale randomized studies conducted 
only with multiple pregnancies, the current scientific data were obtained from 
studies involving multiple pregnancies as well as singleton pregnancies [68]. 
Therefore, in case of an acute preterm labor in multiple pregnancies, short-term 
tocolysis can be administered up to 48 hours to allow for the administration of 
corticosteroids.
7.5.2 Corticosteroids
In a Cochrane review, it was concluded that antenatal corticosteroid is beneficial 
in singleton pregnancies and further studies are required for the outcomes in mul-
tiple pregnancies [69]. However, based on its proven benefits in singleton pregnan-
cies, the National Institute of Health recommends the administration of antenatal 
corticosteroids to pregnant women from 24 to 34 weeks of gestation and who are at 
risk of giving birth within 7 days, unless there is a contraindication, regardless of 
the number of fetuses [70, 71].
7.5.3 Magnesium sulfate for fetal neuroprotection
Magnesium sulfate has been shown to reduce the risk and severity of cerebral 
palsy, regardless of the number of fetuses, at birth before 32 weeks [72–78].
7.6 Prenatal screening in multiple pregnancies
In multiple pregnancies, the probability of one or more fetuses being affected 
by trisomy is mathematically higher than in singleton pregnancies. For example, 
maternal age-dependent risk of trisomy in dizygotic twins is twice as much as 
a singleton pregnancy at the same age [79]. Therefore, the risk of a 33-year-old 
woman expecting twins is equal to that of a 35-year-old singleton pregnant 
woman [80].
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tocolysis can be administered up to 48 hours to allow for the administration of 
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in singleton pregnancies and further studies are required for the outcomes in mul-
tiple pregnancies [69]. However, based on its proven benefits in singleton pregnan-
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corticosteroids to pregnant women from 24 to 34 weeks of gestation and who are at 
risk of giving birth within 7 days, unless there is a contraindication, regardless of 
the number of fetuses [70, 71].
7.5.3 Magnesium sulfate for fetal neuroprotection
Magnesium sulfate has been shown to reduce the risk and severity of cerebral 
palsy, regardless of the number of fetuses, at birth before 32 weeks [72–78].
7.6 Prenatal screening in multiple pregnancies
In multiple pregnancies, the probability of one or more fetuses being affected 
by trisomy is mathematically higher than in singleton pregnancies. For example, 
maternal age-dependent risk of trisomy in dizygotic twins is twice as much as 
a singleton pregnancy at the same age [79]. Therefore, the risk of a 33-year-old 
woman expecting twins is equal to that of a 35-year-old singleton pregnant 
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Aneuploidy screening has many limitations in multiple pregnancies. Serum 
screening tests in twin or triplet pregnancies are not as sensitive as in singleton 
pregnancies. The detection rate of trisomy 21 by the second trimester maternal 
serum screening test in twin pregnancies has been reported to be 63% (71% when 
both fetuses are affected and 60% when only one is affected) with a false-positive 
rate of 10.8% [81]. In the first trimester screening test, where maternal age, nuchal 
transparency, and biochemical markers are evaluated together in twin pregnan-
cies, the detection rate is 75–85% for Down syndrome and 66.7% for trisomy 18, 
with a false-positive rate of 5% [82–85]. Experience with triplet pregnancies is 
scarce, but studies show that screening for only nuchal transparency and maternal 
age is reliable. However, one study has shown that the nuchal transparency above 
the 95th percentile in monochorionic twin pregnancies predicts 38% of twin-
to-twin transfusion syndrome that will develop later, making the interpretation 
of the first trimester screening results even more complicated in monochorionic 
pregnancies [86].
Noninvasive prenatal testing can be used for fetal aneuploidy screening, but 
further data is required to recommend its use in multiple pregnancies [87].
7.7  What are the problems encountered in the prenatal diagnosis of aneuploidy 
in multiple pregnancies?
Women who wish to have a definitive diagnosis of genetic abnormalities may 
have an amniocentesis and chorionic villus sampling (CVS). The procedure-related 
risk of miscarriage for both tests is similar (1–1.8%) and slightly higher compared 
to singleton pregnancies [88–90]. The main advantage of having CVS is that CVS 
is performed earlier in pregnancy. However, in multiple pregnancies, some techni-
cal difficulties are encountered during these procedures. In approximately 1% of 
multiple pregnancies, sample for CVS was collected from the wrong fetus [91]. This 
risk is lower in amniocentesis. To avoid the risk of sampling error, indigo carmine 
is injected into the first sampled sac after amniocentesis. The absence of dye in the 
fluid from the second sac proves that sampling was done from two different sacs. 
Due to the low probability of karyotype being discordant in monochorionic twins, 
pregnant women may prefer karyotype analysis of a single fetus. Thus, the success 
of ultrasound in determining chorionicity should be explained to pregnant women.
When aneuploidy is diagnosed, if a fetus is affected, the parents are offered 
several options, such as termination of the entire pregnancy, selective reduction of 
the affected fetus, or continuation of pregnancy without any intervention.
7.8  What is the prognosis of multiple pregnancies that are discordant in terms of 
the size of the fetuses?
Discordant growth in multiple pregnancies is generally defined as a difference 
of at least 20% between the estimated fetal weights of two fetuses [92, 93]. This rate 
is calculated by dividing the difference between the weights of the two fetuses by 
the weight of the larger fetus. It is controversial whether growth discordance leads 
to negative outcomes in the absence of structural anomaly, aneuploidy, discordant 
infection, oligohydramnios, or fetal growth restriction. There are studies showing 
that fetal or neonatal morbidity and mortality do not increase in cases where weight 
discordance is present but the weight of both fetuses complies with that gestational 
week [94–97]. However, in multiple pregnancies where the growth of at least one 
fetus is limited, major neonatal morbidity increases by 7.7 times [98]. In addition, 
perinatal mortality and morbidity rates were higher in twins with growth restric-




although there is no evidence that neonatal morbidity and mortality increase in 
twins with discordance only, the risk of adverse perinatal outcomes increases in the 
presence of an abnormal finding such as fetal growth restriction accompanied by 
discordance.
7.9 How to manage the death of a fetus?
In the first trimester, spontaneous reduction occurs in one or more fetuses in 
many of the multiple pregnancies [100]. This likelihood of reduction is propor-
tional to the number of gestational sacs (36% in twins, 53% in triplets, 65% in qua-
druplets [101]). In the second or third trimester, the death of one or more fetuses 
is seen in 5% of twins and 17% of triplets [102]. Chorionicity affects the loss rate 
and helps determine the prognosis and manage the living fetus. In monochorionic-
diamniotic twins, the rate of fetal death is higher than in dichorionic-diamniotic 
twins [103–105]. In fetal deaths after the 14th week of pregnancy, the probability of 
death of the other twin is 15% in monochorionic twins and 3% in dichorionic twins 
[105]. The probability of developing neurological abnormalities in the living fetus is 
18% in monochorionic twins and 1% in dichorionic twins [106, 107]. Despite these 
risks, the immediate delivery of the other twin has no benefit [108]. Therefore, in 
monochorionic twin pregnancies, if one of the fetuses dies before the 34th gesta-
tional week, the pregnancy should be managed according to the mother and the 
living fetus. Unless there is another indication, delivery should not be done before 
34th week [109]. The timing of birth should be determined according to the patient 
and in consultation with those trained in maternal-fetal medicine.
7.10 How to perform antepartum fetal follow-up in dichorionic pregnancies?
After determining chorionicity in the first or early second trimester, the 
anatomy, size, amount of amniotic fluid, and placenta should be evaluated with 
ultrasound at 18–22 weeks of gestation. The growth rate of fetuses in uncomplicated 
twin pregnancies is approximately the same as single pregnancies up to 28–32 weeks 
[110]. Although there is no scientific evidence suggesting that ultrasound should 
be performed to evaluate fetal growth after the 20th week, it seems reasonable to 
monitor dichorionic twin pregnancies without fetal growth restriction or other 
pregnancy complications every 4–6 weeks with serial ultrasound.
It has not been shown that antepartum tests or umbilical artery Doppler ultra-
sound improves perinatal outcomes in uncomplicated twin pregnancies [111]. Tests 
evaluating fetal well-being in dichorionic twins should only be used when there are 
fetal or maternal complications such as fetal growth restriction.
7.11 How to manage complications caused by monochorionic placentation?
Monochorionic pregnancies should be monitored more closely than dichorionic 
twins because of the higher risk of complications [112]. Monitoring of pregnancy 
with serial ultrasound every 2 weeks from the 16th week should be considered 
[113–115].
7.11.1 Twin-to-twin transfusion syndrome
Twin-to-twin transfusion syndrome develops in approximately 10–15% of 
monochorionic-diamniotic pregnancies and is due to arteriovenous anastomoses 
in the monochorionic placenta. It usually occurs in the second trimester and is 
diagnosed by the presence of oligohydramnios (the largest vertical pocket is smaller 
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than 2 cm) in one sac and polyhydramnios (the largest vertical pocket is larger than 
8 cm) in the other sac. A fetal discordance and selective fetal growth restriction due 
to structural and genetic anomalies or infectious diseases should be ruled out. The 
benefits of umbilical artery Doppler have not been demonstrated in cases where 
there is no growth and fluid discordance. The prognosis of twin-to-twin transfusion 
syndrome varies by the week of gestation and the severity of the syndrome. Staging 
is based on the Quintero classification system shown in Table 1, and treatment with 
laser coagulation or amnioreduction therapy is frequently used [112, 116].
7.11.2 Monoamniotic twins
The natural incidence of monoamniotic twin pregnancy is one in 10,000, but 
the incidence may be higher in zona-manipulated IVF pregnancies [117]. Perinatal 
mortality rates associated with cord complications have been reported as high as 
80% [118]. Although the ideal management of these pregnancies is not clearly 
known, daily fetal heart monitoring in hospital conditions from 24 to 28 weeks 
of gestation and delivery at 32–34 weeks of gestation are the common practice 
[118–120].
7.11.3 Rare complications
Acardiac twin pregnancy occurs in 1% of monochorionic pregnancies and is 
characterized with a fetus that does not have a normally developed heart and brain 
[121]. This fetus continues to live by the anastomoses in the placenta and the blood 
supplied by the other fetus (pumping twin). Therefore, the pumping fetus is at risk 
of cardiac insufficiency, and intrauterine or neonatal loss occurs in nearly half of 
the cases [122]. This rare condition should be managed by a maternal-fetal medicine 
specialist experienced in twin pregnancy management.
Conjoined twin is a rare phenomenon, occurring 1 in 50,000–100,000 [123]. 
After the diagnosis, it should be determined which organs are shared for the prog-
nosis [124]. The survival rate of a conjoined twin detected in the intrauterine period 
is only 18% even after successful surgery [125].
7.12 What should be the time and mode of delivery in multiple pregnancies?
The time of spontaneous delivery in twin pregnancies is around 36 weeks, and 
so the complications of prematurity are an important risk [126]. Perinatal mortality 
increases again after 38 weeks of gestation [127]. Accordingly the time of delivery 
for uncomplicated twin pregnancies would be reasonable [108]:
a. At 38 weeks in dichorionic diamniotic twins without complications
b. From 34 to 37 6/7 weeks in monochorionic-diamniotic pregnancies without 
complications
c. From 32 to 34 weeks in monoamniotic pregnancies without complications
The ideal mode of delivery varies by the type of twin pregnancy, the presen-
tation of the fetuses, the gestational week, and the experience of the delivering 
physician. Twin pregnancy alone is not an indication of cesarean section [128]. 
In monoamniotic pregnancies only, cesarean delivery is required to avoid cord 





In a recently published randomized controlled study, no difference was reported 
between planned cesarean and planned vaginal delivery in terms of fetal and neo-
natal death or severe neonatal morbidity between 32 and 38 6/7 weeks of gestation 
in twin pregnancies with cephalic presentation of the first fetus [129]. Therefore, in 
diamniotic twin pregnancies with cephalic presentation of the first fetus after the 
32nd gestational week, vaginal delivery appears to be a logical option, regardless of 
the presentation of the second fetus, provided that the obstetrician is experienced 
in internal podalic version and vaginal breech delivery [130].
The ideal delivery method in higher-order multiple pregnancies is not known. In 
small observational studies, there was no significant difference between planned vag-
inal delivery and planned cesarean delivery with the cephalic presentation of the first 
fetus in uncomplicated triplet pregnancies. Therefore, planned vaginal delivery may 
be considered in these pregnancies if obstetrician is experienced [131–133]. Vaginal 
delivery can be attempted in twin pregnancies with a previous history of cesarean 
section with a single lower transverse incision and without any contraindications for 
vaginal delivery [134–138]. Internal fetal manipulation or emergency cesarean sec-
tion may be required during delivery. Women with multiple pregnancies are at risk 
for atony, postpartum bleeding, and emergency hysterectomy [139]. The administra-
tion of neuroaxial analgesia facilitates operative vaginal delivery, external or internal 
cephalic version, and total breech extraction in multiple pregnancies [130].
8. Summary of findings and recommendations
A. Recommendations based on reliable scientific data (with evidence level A)
• No tocolytic agent is recommended for prophylactic use in multiple 
pregnancies.
• Treatment with progesterone does not reduce the incidence of spontaneous 
preterm delivery in twin and triplet pregnancies.
B. Recommendations based on limited scientific data (with evidence level B)
• Chorionicity should be determined in the late stages of the first trimes-
ter or in the early stages of the second trimester due to complications of 
monochorionicity.
• Since prophylactic tocolysis, prophylactic cerclage, prophylactic pessary, 
routine hospitalization, and bed rest have not been shown to reduce neonatal 
Stage 1.  Monochorionic-diamniotic gestation with oligohydramnios (MVP less than 2 cm) and 
polyhydramnios (MVP greater than 8 cm)
Stage 2. Absent (empty) bladder in donor
Stage 3. Abnormal Doppler ultrasonography findings*
Stage 4. Hydrops
Stage 5. Death of one or both twins
Abbreviation: MVP, maximum vertical pocket. Data from [140].
*Defined as the presence of one or more of the following: umbilical artery absent or reversed diastolic flow; ductus 
venosus absent or reversed diastolic flow; or umbilical vein pulsatile flow.
Table 1. 
Staging of twin-to-twin transfusion syndrome.
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morbidity and mortality, these practices are not recommended in multiple 
pregnancies.
• Magnesium sulfate has been shown to reduce the risk and severity of cerebral 
palsy, regardless of the number of fetuses, at birth before 32 weeks.
• In women with a previous history of cesarean section with a transverse inci-
sion to the lower segment, vaginal delivery can be attempted unless there is 
another contraindication.
• In pregnancies in which the number of fetuses is reduced from three to two 
with embryo reduction, pregnancy loss, antenatal complications, preterm 
delivery, low birth weight, and cesarean and neonatal mortality rates are 
lower than in pregnancies continuing as triplets and are similar to spontane-
ous twin pregnancies.
• Unless there are contraindications, a cycle of antenatal corticosteroid should 
be administered to women pregnant with multiples from 24 to 34 weeks of 
gestation and who are expected to give birth within 7 days regardless of the 
number of fetuses.
C. Recommendations based on expert opinion (with evidence level C)
• Delivery in uncomplicated monoamniotic twins should be at 32–34 weeks of 
gestation.
• In diamniotic twin pregnancies over 32 0/7 weeks with cephalic presentation 
of the first fetus, vaginal delivery appears to be a logical option, regardless 
of the presentation of the second fetus, provided that the obstetrician is 
experienced in internal podalic version and vaginal breech delivery.
• Women with multiple pregnancies are candidates for routine aneuploidy 
screening regardless of age.
• Administration of neuroaxial (epidural) analgesia in multiple pregnancies 
facilitates operative vaginal delivery, external or internal cephalic version, 
and total breech extraction.
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Abstract
Abt-Letterer-Siwe disease is a form of Langerhans cell histiocytosis and occurs 
in 2–10 cases per 1 million of the child population per year. The Russian and foreign 
literature provide descriptions of this disease in children of different ages. Family 
cases of this pathology are described in a small number. The chapter presents a rare 
clinical observation of the Abt-Letterer-Siwe disease in twin girls.
Keywords: langerhans cell histiocytosis, Abt-Letterer-Siwe disease, children, twins, 
family case
1. Introduction
Langerhans cell histiocytosis (LCH) is a disease associated with abnormal 
proliferation and accumulation in the organs and tissues of pathological Langerhans 
cells, leading to local damage and violation of the affected organ function [1]. The 
term LCH includes eosinophilic granuloma, Hand-Schuller-Christian, and Abt-
Letterer-Siwe diseases. The latter is considered the most difficult option with a 
mortality rate of at least 50% [2]. The study of Abt-Letterer-Siwe disease was started 
in 1924 by a German pathologist Erich Letterer [3]. In 1933, a Swedish pediatrician 
Sture Siwe published the first clinical description of the disease and proposed criteria 
for diagnosis [4]. In 1936, American authors Arthur Abt and Edward Denenholz in 
their publication proposed the adoption of the term “Letterer-Siwe disease” [5]. The 
disease is also mentioned in the literature as “Abt-Letterer-Siwe disease.”
The LCH frequency is 2–10 cases per 1 million children in a year [1, 6–10]. Boys 
have this disease 1.5–2 times more often than girls, mainly in early childhood [1]. 
The skeleton (60–80%), skin (22–50%), lymph nodes (10–15%), liver (10–15%), 
bone marrow (10–15%), lungs (10–15%), endocrine glands (25%), central nervous 
system (2–4%), etc. [1, 11–13] may be involved in pathological process. These 
lesions are specific for Hand-Schuller-Christian and Abt-Letterer-Siwe diseases, but 
the latter is characterized by severity of the course, generalization of the process, 
and onset in the first years of life [7, 14, 15].
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The skeleton (60–80%), skin (22–50%), lymph nodes (10–15%), liver (10–15%), 
bone marrow (10–15%), lungs (10–15%), endocrine glands (25%), central nervous 
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the latter is characterized by severity of the course, generalization of the process, 
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The involvement of skin in the process in 10% may be the only symptom [7, 13]. 
LCH foci on the skin are represented by yellowish-red, dense, highly itchy papules 
and nodules with a slight hemorrhagic hue, cracking is specific. Elements are 
localized in the retroauricular region, in large folds of the body. The scalp is 
affected like a seborrheic eczema type. With the development of the disease, the 
dissemination of rash occurs. For skin rash in case of LCH, a poor response to 
treatment with topical glucocorticosteroids is typical. In case of damage to the oral 
mucosa, ulcers with fibrinous plaque are formed [7]. The involvement of many 
organs and systems in the pathological process leads to the appearance of defects 
in the bones (mainly in flat bones), impaired hemostasis, lymphadenopathy, hepa-
tosplenomegaly, and suppression of bone marrow function. Damage to the lungs is 
manifested by the spontaneous pneumothorax occurrence. Long, recurrent course 
of otitis is specific [1, 7, 14].
A probable clinical diagnosis is confirmed by histopathological and immu-
nohistochemical methods. A biopsy of skin, osteolytic foci, and lymph nodes is 
preferred. Liver or lung biopsy is performed in the absence of other materials [1]. 
Light microscopy does not allow an unambiguous diagnosis. The “gold standard” of 
diagnosis is the identification of Birbeck granules by electron microscopy. A more 
sensitive and specific diagnostics is immunohistochemical staining with langerin 
(CD 207), which is a monoclonal antibody against type II transmembrane protein 
bound to the Birbeck granules [13].
According to the data of Moskacheva et al., until 1931, about 65 cases of Hand-
Schuller-Christian disease and 4 cases of Abt-Letterer-Siwe disease were described. 
According to other authors to 1955 described about 350 and 68 cases of the disease 
it [15]. In the Russian Scientific Electronic Library in the period from 2004 till 2017, 
about 8 clinical observations of this disease in children were described. PubMed’s 
English language text database for the same period represents more than 300 
sources, including cases of Abt-Letterer-Siwe.
Until the middle of the twentieth century, the relationship of Abt-Letterer-Siwe 
disease with genetic disorders was questioned [5, 15]. The described family cases 
in siblings and, moreover, cases of the disease in twins were of particular interest. 
The Russian language descriptive works of the LCH family cases, including the 
disease Abt-Letterer-Siwe, in the Russian Scientific Electronic Library for the last 
10–15 years are absent. Over the past 50–60 years, we have found about 40 LCH 
familial cases (half of Abt-Letterer-Siwe disease) in the PubMed database, of which 
12 are twins with a description of the disease.
Due to the pathology rarity, we represent a description of the Abt-Letterer-Siwe 
disease case in two monozygotic twin girls A and E, who were admitted to our clinic 
at the age of 12 months.
2. Description of the Abt-Letterer-Siwe disease case
Children are from monozygotic twins from one pregnancy. Parents are young 
and healthy. Delivery occurred at a period of 34 weeks. Both children were switched 
to artificial feeding during the first month. The development of children through-
out the observation period corresponded to the age.
For the first time, parents noted the appearance of moderately itchy skin rash 
and ulcerative stomatitis in children at the age of 1.5–2 months. Hyperemia, papules, 
crusts were present in the area of large skin folds (cervical, axillary, inguinal). The 
boundaries of skin changes were legibly delineated (Figure 1). Quickly enough, the 
scalp (hyperemia, severe desquamation, yellowish crusts, papules) and the parotid 
area (hyperemia, crusts, papules, weeping) were involved in the process. Rare small 
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papules and pustules occasionally appeared on the skin of the limbs and trunk (out-
side the folds), which was considered as pyodermia. Secondary changes, such as small 
scars, remained in place of some papules and pustules. In a retrospective assessment, 
it is possible that there were small nodules on the skin. Children received antihista-
mines, care cosmetics, and topical corticosteroids; milk mixtures were changed. No 
improvement was observed. The application of topical corticosteroids to the affected 
areas exacerbated itching and hyperemia, and anxiety appeared in children.
Over the next 4–5 months, against the background of the treatment variety, 
skin manifestations persisted in a stable condition of children and sufficient weight 
gain. On the scalp (“seborrheic area”) and the parotid region, yellowish crusts, 
erythema, peeling, papules, and weeping were observed.
The main changes were localized in large folds, which were manifested by 
hyperemia, papules, crusts, and cracks. Soles, palms, and interdigital spaces were 
involved in the process, where hyperemia, peeling, yellowish crusts, and cracks 
were observed. The skin of the limbs, trunk, and face was intact, with the exception 
Figure 1. 
Skin changes: inguinal fold (a) and neck fold (b).
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papules and pustules occasionally appeared on the skin of the limbs and trunk (out-
side the folds), which was considered as pyodermia. Secondary changes, such as small 
scars, remained in place of some papules and pustules. In a retrospective assessment, 
it is possible that there were small nodules on the skin. Children received antihista-
mines, care cosmetics, and topical corticosteroids; milk mixtures were changed. No 
improvement was observed. The application of topical corticosteroids to the affected 
areas exacerbated itching and hyperemia, and anxiety appeared in children.
Over the next 4–5 months, against the background of the treatment variety, 
skin manifestations persisted in a stable condition of children and sufficient weight 
gain. On the scalp (“seborrheic area”) and the parotid region, yellowish crusts, 
erythema, peeling, papules, and weeping were observed.
The main changes were localized in large folds, which were manifested by 
hyperemia, papules, crusts, and cracks. Soles, palms, and interdigital spaces were 
involved in the process, where hyperemia, peeling, yellowish crusts, and cracks 
were observed. The skin of the limbs, trunk, and face was intact, with the exception 
Figure 1. 
Skin changes: inguinal fold (a) and neck fold (b).
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of rare episodes of pustular rash. Despite extensive and persistent skin lesions, 
itching was moderate. During the periods of exacerbation, children became restless 
due to pain.
The dermatologist examined the children at the age of 7 months for the first time. 
Bright erythema-squamous rash with weeping and mucous discharge in the area of 
large folds were described, scars after previous pustulosis. Erythematous diaper rash 
and atopic dermatitis were diagnosed. Antihistamines, topical glucocorticoids, and 
antibiotics were administered as treatment. After 2 weeks, no significant dynamics 
were observed.
At the age of 9 months, the dermatologists in the clinic diagnosed an infant form 
of atopic dermatitis. Skin symptoms were the same. On the part of the internal organs 
and in blood tests, no significant pathology was detected. In bacteriological studies 
from the inguinal, axillary, and neck folds, Staphylococcus aureus was identified. Girls 
received a dairy-free diet, a solution of potassium permanganate on the affected skin 
folds, nystatin, hydrocortisone + oxytetracycline, and papaverine ointment. Children 
were discharged without improvement at the age of 9 months 3 weeks with recom-
mendations for treatment of intestinal dysbiosis, a hypoallergenic diet and continued 
local therapy.
At the age of 11 months, the children were examined by a pediatrician in the 
consultation center. During physical examination, the attention was paid to the 
course of the disease, which was atypical for atopic dermatitis—localization of 
rash was mainly in skin folds of the “diaper dermatitis” type of dark-red color 
with a relatively intact remaining surface, damage of the palms, soles, interdigital 
spaces of the feet, ulceration of the oral mucosa in the onset, episodes of pustular 
rash with an outcome in small scars, repeated worsening of symptoms (increased 
hyperemia, increased itching, and the appearance of pain) when using topical 
glucocorticosteroids, the absence of any improvement after the exclusion of cow’s 
milk protein from the diet (at the time of the consultation, the children received a 
high-hydrolysis formula for a long time and scanty complementary foods). The girls 
showed periodic weeping in the ears area, damage of the entire scalp like a sebor-
rhea type, which had an unusually stubborn course. An anamnesis of the disease, 
clinical picture, absence of the effect of glucocorticosteroids, and a therapeutic diet 
excluded the atopic dermatitis diagnosis.
At the age of 12 months, the condition worsened and the children were admit-
ted to our clinic. Children had fever up to 39–40°C, intoxication, and moderate 
hepatosplenomegaly. Skin symptoms significantly increased (Figure 2). In the 
clinical blood analysis of girls A and E, anemia (erythrocytes 3.32 and 3.58*1012/L, 
and hemoglobin 75 and 84 g/L, respectively), leukocytes at level 5.8*109/L and 
9.3*109/L, respectively, thrombocytopenia (platelets 66 and 108*109/L, respec-
tively), and ESR 20 mm/h in both girls were observed. The range of differential 
diagnosis included primary immunodeficiency, psoriasis, and LCH. During one 
day, the children received intravenous immunoglobulin based on the course 
dose of 1 g/kg due to the severity of the condition and a probable diagnosis of 
immunodeficiency.
The condition of children remained serious due to an increase in hematological 
disorders (anemia—hemoglobin up to 70–90 g/L, thrombocytopenia up to single 
cells, and leukopenia up to 3–4 M09/L), hemorrhagic (bleeding of elements in 
large-folds) and hepatolienal syndromes, fever up to 39–40°С, and infection of the 
skin—primarily with “wild,” and then with hospital strains of bacteria. An intensive, 
replacement therapy and an antibiotic therapy were applied.
During treatment, a temporary improvement was observed in the form of 
drying, reduction of purulent crusts, and improvement of well-being. On the 10th 
day of hospitalization, child A developed a septic shock. In the intensive care unit, 
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the girl was on the mechanical ventilation of lungs for 10 days. The condition of the 
second child remained stably severe.
Both girls excluded HIV infection, primary immunodeficiencies of the humoral, 
cellular, and phagocytic parts of the immune system, and violation of complement. 
Specific lesions of bones and lungs were excluded according to X-ray and computed 
tomography (CT) results. In child E, according to spiral CT, a left-sided otitis media 
was observed without destructive changes. According to bone marrow puncture, in 
Figure 2. 
Dynamics of skin changes: foot skin lesion (a) and inguinal areas (b).
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Dynamics of skin changes: foot skin lesion (a) and inguinal areas (b).
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child A, the process disorders differentiation and the maturation of cells were not 
determined, the erythroid germ was expanded, and a moderate delay in maturation 
at the level of myelocytes was observed in the granulocytic germ. Megakaryocytes 
were not found during the study. Free platelets were isolated.
In a cytological study of smear impressions from the creases in child A, in addition 
to inflammatory elements and eosinophils, cells with hyperchromic sharply enlarged 
nuclei, with signs of nuclear polymorphism and atypia, and binuclear cells were 
found. Atypical large cells with an oval nucleus, fine-grained chromatin, containing 
1–2 nucleoli, and an abundant pale-stained cytoplasm were visualized in a significant 
amount. Some cells contained vacuoles.
The child A underwent a skin biopsy from a pathological focus. Light micros-
copy in the papillary layer at the border with the epidermis revealed single foci 
of proliferation of large oval and process cells with an eosinophilic cytoplasm, 
hyperchromic nuclei, and single binuclear cells. The described that the morphology 
was specific for histiocytosis. In the Federal State Budgetary Institution “National 
Medical Research Center named after Dmitry Rogachev” (Moscow), an immuno-
histochemical study was performed. According to this analysis, large cells express 
Langerin, CD13, and single cells express CD68. Reactions with other antibodies to 
them are negative. Conclusion: LCH.
Two weeks after admission to the hospital, an intravenous administration of 
glucocorticosteroids at a dose 20 mg/kg was started in pulse mode 3 times a week with 
further switch to oral administration of prednisolone at a dose 2 mg/kg. Confirmation 
of the LCH diagnosis (Abt-Letterer-Siwe disease) made it possible to continue therapy 
according to the LCH III protocol in the Pediatric Oncohematology Department. 
Against the background of some stabilization of the condition, episodes of fever, 
hepatosplenomegaly, pancytopenia in the clinical blood analysis, and bleeding 
persisted. Rash in large skin folds was without significant dynamics. Taking it into 
account, a lack of response to therapy was reported. Children were directed to the 
Federal State Budgetary Institution “National Medical Research Center named after 
Dmitry Rogachev” (Moscow) for further treatment.
Our clinical case of Abt-Letterer-Siwe disease is one of the most severe LCH 
variants. In children, there was a multisystem lesion, involving the liver, hemato-
poietic system, and spleen, which is prognostically unfavorable. A feature of the 
described case is the simultaneous onset of the disease in two twin girls, which is 
an extremely rare observation. This clinical case shows the difficulty in diagnosing 
LCH (Abt-Letterer-Siwe disease) at an early age. Difficulties in making a diagnosis 
arise when there is still no developed clinical symptomatology of the disease or the 
clinical picture is inapparent [15]. The prevalence of damage to one organ or system, 
especially at the beginning of the disease, leads to erroneous diagnoses. In our clini-
cal case, the main symptom of the disease during 10–11 months in both girls was 
skin damage. During this period of time, they were observed by pediatricians and 
dermatologists with a diagnosis of atopic dermatitis and diaper rash.
3. Conclusions
In our opinion, the attending physician should have been alerted by a number 
of symptoms that are not specific for atopic dermatitis: ulcerative stomatitis in the 
onset; absolutely unspecific localization of the rash—large folds without damage to 
the skin areas typical for atopic dermatitis at this age; unusual coloring of elements 
(dark-red); damage of the palms, soles, and interdigital spaces; episodes of an abscess 
rash that left small scars—this symptom indicates a deeper lesion of the skin than 
with ordinary pyodermia; and one of the significant symptoms is the deterioration 
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of skin symptoms with the “gold standard” topical application treatment of atopic 
dermatitis—topical glucocorticosteroids. The latter manifestation is typical for the 
Abt-Letterer-Siwe disease, but is absolutely not specific for allergic rash.
Thus, at present, the diagnosis of orphan diseases remains difficult at the early 
stages. This is due to the polymorphism of manifestations, the rarity of cases, and 
the similarity with other nosologies.
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